Studies on human placental alkaline phosphatase by Abu-Hasan, Nael Sudqi
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
 
 
 
 
 
Abu-Hasan, Nael Sudqi (1983) Studies on human placental alkaline 
phosphatase. PhD thesis. 
 
http://theses.gla.ac.uk/5892/ 
 
 
 
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
 
STUDIES ON HUMAN PLACENTAL ALKALINE PHOSPHATASE 
A thesis submitted for the Degree of 
Doctor of Philosophy at the 
University of Glasgow 
by 
NAEl.. SUDQI t!BU-HASAN 
Institute of Genetics 
Church Street 
Glasgow 
December 1983 
DECLARATION 
I declare that this thesis has been composed by myself and has 
not been accepted in any previous application for a degree. The 
work is my own except where specifically acknowledged. 
ACKNOWLEDGEMENTS 
I am profoundly grateful to Dr. Roger Sutcliffe for his tremendous 
effort, encouragement and constructive advice throughout the course of 
this research, not only as a supervisor, but as a great personal friend. 
I am indebted to An-Najah National University (Nablus, West Bank) 
for giving me the opportunity to continue my higher education and for 
their financial support. I gratefully acknowledge the provision of 
grants by the British Council and the Committee of the Vice-Chancellors 
and Principals. My sincere thanks to Professor David Sherratt for 
allowing me to pursue my studies in the Genetics department and for his 
tireless effort in solving my financial problems. Thanks are due to Dr. 
P. J. Findlay of the SERC protein sequencing laboratory, Leeds 
University, Dr. Peter Johnson for a gift of antisera and to Dr. Nabil 
Afara for proof reading my thesis. I also wish to extend my thanks to 
Dr. Richard Wilson and Dr. Eldridge Buultjens for their helpful 
discussions, and all the rest of the academic and technical staff in the 
institute for their friendship, help and hospitality contributing to an 
excellent environment during the course of this work. I also thank the 
staff of the labour suite at the Queen's Mother Hospital, Glasgow, for 
their time, assistance and gifts of material. 
Last, but not least, I wish to thank my wife and my family who 
supported me morally and financially during the years of my studies. 
CONTENTS 
SUMMARY 
ABBREVIATIONS 
CHAPTER 1: INfRODUCTION 
1 : 1 
1 :2 
1: 3 
1: 3. 1 
1: 3.2 
1:3.3 
1:3.4 
1: 4 
General introduction 
The syncytiotrophoblastic microvillous plasma 
membranes 
Alkaline phosphatases 
Genetic and biochemical distinctions between 
human alkaline phosphatase isoenzymes 
Placental alkaline phosphatase polymorphism 
Synthesis and molecular heterogeneity of placental 
alkaline phosphatase during pregnancy 
Tumour-related alkaline phosphatases 
Membrane proteins 
CHAPTER 2: ALKALINE PHOSPHATASE AS A HARKER FOR HUMAN 
PLACOOAL MICROVIUDUS HDmRANES 
2:1 Introduction 
2:2 Materials and methods 
2:2.1 Materials 
2:2.2 Methods 
1. Plasma membrane preparations 
2. Extraction of alkaline phosphatase 
3. Column chromatography 
4. Electrophoresis 
5. Assays 
2:3 Results 
2:3.1 Starch gel electrophoresis 
2:3.2 Chromatography 
2:4 
·2:4.1 
2:4.2 
2:4.3 
Discussion 
Nature of the M form 
Location 
Some implications 
page number 
i 
v 
1 
1 
4 
7 
7 
13 
16 
19 
23 
29 
29 
30 
30 
31 
31 
32 
32 
34 
34 
37 
45 
45 
47 
48 
CHAPTER 3: PURIFICATION AND CHARACTERIZATION OF 50 
MICROVIllOUS ALKAUNE POOSPHATASE 
3: 1 Introduction 50 
3:2 Materials and methods 51 
3:2.1 Materials 
3:2.2 Methods 
1. Preparation and extraction of microvilli 51 
2. Column chromatography 51 
3. Electrophoresis 52 
4. Reduction and alkylation 52 
5. Isoelectric focusing 53 
6. Cyanogen bromide (CNBr) fragmentation of proteins 53 
7. Hydrophobic chromatography 54 
8. Assays 54 
3:3 
3:3.1 
3:3.2 
3:3.3 
3:3.4 
3:3.5 
3:3.6 
3:4 
Results 
Ion-exchange chromatography 
Polyacrylamide gel electrophoresis 
Reduction, alkylation and isoelectric focusing 
Cyanogen bromide fragmentation of PAP 
Hydrophobic chromatography 
Enzyme kinetics 
Discussion 
55 
55 
55 
58 
58 
59 
59 
67 
CHAPTER JJ: INTEGRATION OF PUC ENTAL AlKALINE POOSPHATASE 72 
INTO MICROVIllOUS HFl4BRANES 
4: 1 Introduction 72 
4:2 Materials and methods 73 
4:2.1 Materials 
4:2.2 Methods 
1. Proteinase treatment of microvillous membranes and 73 
proteins 
2. Identification of the amino-terminal amino acids 74 
3. Polyacrylamide gel electrophoresis 74 
4:3 
4:3.1 
4:3.2 
4:3.3 
4:3.4 
4:3.5 
4:4 
4:4.1 
4:4.2 
4:4.3 
Results 
Released enzyme activity 
Electrophoresis and chromatography of 
subtilisin released PAP 
Amino-terminal sequence 
The behaviour of subtilisin-cleaved PAP on 
non-reducing SDS gels 
The effect of trypsin solubilization on PAP 
Discussion 
Location of the membrane binding domain 
Conformational heterogeneity 
Native molecular weight estimates 
75 
75 
75 
77 
79 
79 
86 
86 
89 
91 
CHAPTER 5: GENERAL DISCUSSION 
5:1 
5:2 
5:3 
5:4 
Further characterization of the C-termini 
The need for molecular biological studies 
The nature and origin of serum placental 
alkaline phosphatase. 
Candidate substrates for placental alkaline 
phosphatase 
BIR.IOGRAPHY 
APPENDIX: PUILISHID PAPERS 
93 
96 
98 
99 
100 
102 
119 
SUMMARY 
Human placental alkaline phosphatase (PAP) is evolutionarily 
distinct from that of liver, bone, kidney, and intestine. Although 
histochemical, immunological and biochemical studies had shown that PAP 
is a major protein component of the syncytiotrophoblastic microvillous 
plasma membranes of the placenta, there is little information on the 
structure of the enzyme purified from these membranes, or the means of 
its integration into these membranes. Previous work has shown that 
these microvilli can be sub-fractionated into two distinct fractions. 
However, the nature and origin of these fractions was not clear. 
The purpose of this investigation was to confirm the placental 
origin of these fractions of microvilli using placental alkaline 
phosphatase as a marker and to see whether PAP in these preparations is 
similar to that of the A and B forms of the enzyme extracted from the 
whole placental tissue. 
When butanol extracts of these microvilli and their fractions were 
analysed on starch gels, a considerable amount of enzyme activity either 
failed to enter the gel system or caused a smear between the A and B 
zones of activity. This smearing was resolved into a discrete band of 
enzyme acti vi ty located between the A and B forms of the enzyme after 
the incorporation of Tri ton X-100 irto the gel system. This band was 
called the M form of PAP and appears to be largely or wholly specific 
for microvilli. It was also found at very low concentration relative to 
the A and B forms in extracts of total placental tissue. The reasons 
which may account for the failure of previous investigations to observe 
this form (M-PAP) are their enzyme preparations were obtained from 
throughly washed placental tissue, which will wash off the microvilli, 
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and their starch gel systems did not involve the use of Triton X-100, 
which is essential for this band to enter the gel. 
Experiments were included to investigate whether this form of PAP 
could be generated through artifactual aggregation of either A or B 
polypeptides or both. A variety of experiments show that the M form is 
not an artifact of extraction. Serological, heat-stability and genetic 
studies showed that the A and M forms contain the same enzymatic 
polypeptide. Gel filtration of butanol extracts of microvilli provided 
an estimated molecular weight of 725,000; this value was not altered by 
extracting the enzyme from the placental microvilli in Triton X-100, or 
by equilibrating filtration columns with detergent. 
To study the polypeptide composition of M-PAP in comparison with 
that of A-PAP, both forms of the enzyme were purified to homogeneity 
from butanol extracts of syncytiotrophoblastic microvillous membranes 
using DEAE Sepharose CL-6B chromatography and were subjected to several 
biochemical investigations. The two isoenzymes had indistinguishable pH 
optima and Km values. Under reducing conditions 1n SDS polyacrylamide 
gels, both forms showed a similar subunit molecular weight of 69,000. 
In the absence of reduction M-PAP was present in a dimeric form similar 
to A-PAP. However, the mobility of the dimer of M-PAP corresponded to a 
molecular weight of 116,000 compared with 130,000 for A-PAP. It was 
concluded that this difference is due to the A and M dimers being in 
different conformations. In SDS gels the M form also showed a higher 
molecular weight species corresponding to a mobility of 180,000, but 
species corresponding to 725,000 were not found. Under different 
alkylating conditions the polypeptide subunit of both forms showed 
similar isoelectric banding patterns. The M-PAP showed some extra bands 
with relatively high pI values. CNBr fragmentation also yielded very 
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similar methionine cleaveage patterns in both polypeptides. 
The hydrophobicity of the different forms of PAP were tested on 
various columns of hydrocarbon-coated agaroses. This study supports the 
view that M-PAP is hydrophobic relative to the A and B forms, and 
provided a potentially simple method of purifying M-PAP. 
To study the mode of integration of M-PAP into the plasma membrane, 
the enzyme was extracted from micovilli either by butanol extraction or 
subtilisin proteolysis. The results indicate that subtilisin cleavage 
of PAP removes a membrane binding domain of approximately 2,000 
molecular weight, leaving the catalytic site intact and the remaining 
portion of the protein in solution. Sequencing studies on the N-
terminal 13 amino acids of both the subtilisin cleaved and uncleaved 
forms of M-PAP indicated that the enzyme is anchored to the plasma 
membranes by its carboxy-terminus. The N-terminal 13 amino acids of A-
PAP were the same as those of M-PAP. On SDS gels the subtilisin-
cleaved M-PAP showed an apparent dimeric molecular size bigger than that 
of the original uncleaved enzyme, presumably due to the generation of a 
less compact conformational state. Variations in the electrophoretic 
mobilities of the different allelic forms of PAP were also observed in 
these gels. On both gel filtration and ion-exchange chromatography, 
cleaved M-PAP showed elution patterns similar to that of A-PAP. On 
starch gels, cleaved M-PAP did not require the presence of Triton X-100 
to enter the gel and showed a single zone of enzyme activity with a 
mobility slightly faster than that of A-PAP. 
Trypsin solubilization failed to release M-PAP from these 
membranes. It appeared to cleave a portion of a molecular weight of 
about 9K from the amino terminus, leaving an enzymatically active 
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portion of PAP associated with the membrane. 
The available evidence demonstrates the existence of a new form of 
PAP in association with the microvillous plasma membranes of the 
placenta. This form of the enzyme seems to share at least part of the 
same enzymatic polypeptide with the non-membranous form (A-PAP) and 
appears to differ from it in having a hydrophobic anchoring domain at 
its carboxy-terminus. The precise relationship of the membrane binding 
domain to the bilayer is not yet understood. At this stage we can not 
speculate into the biogenetic relationship between membranous and non-
membranous forms of PAP, however, the possibility should be considered 
that the pathway for the synthesis of secretory and membrane IgM may 
also be applicable to PAP forms, and therefore have a general biological 
significance. Direct biogenetic studies will be necessary to obtain 
complete information on this problem. 
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ABBREVIATIONS 
AP Alkaline phosphatase 
PAP Placental alkaline phosphatase 
~2M Alpha-2-macroglobulin 
BSA Bovine serum albumin 
Alb Human serum albumin 
Tf Human transferrin 
SP3 Pregnancy associated protein 3 
PBS Phosphate-buffered saline: O.16M NaCl, 5mM potassium 
phosphate, pH 7.5 
SDS Sodium dodecyl sulphate 
CNBr Cyanogen bromide 
pI Isoeletric point 
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CHAPTER 1 
INTRODUCTION 
1: 1 GENERAL INTRODUCTION 
The architecture of the chorionic villi is a key factor in the 
function of the hUman placenta. In the first trimester of pregnancy the 
villi are relatively few in number and their outer surface is covered by 
two distinct layers of epithelium: an outer layer of syncytiotropho-
blast and an inner of cytotrophoblast (Langhans' cells). The syncytio-
in 
trophoblast is uniform/thickness and has a free surface covered by large 
microvilli that are normally about 0.5 to 1.2 J.lm in length and their 
cytoplasm is continuous with that of the syncytiotrophoblast (Fox, 
1978). Between the microvilli, the syncytial surface is often 
invaginated to form areas which are the precursors of pinocytotic 
vesicles. The basal plasma membrane of the syncytiotrophoblast shows 
complex infoldings, resulting in an interrupted extracellular space 
between the syncytium and cytotrophoblast. Desmosomes are often present 
where the syncytium is in direct contact with a cytotrophoblastic cell 
(Fox, 1978). Under the electron microscope, the immature syncytium 
contains an abundance of rough endoplasmic reticulum, which is usually 
dilated to give an overall vacuolated appearance to the cytoplasm. Free 
ribosomes are abundant and tend to occur in clusters or rosettes. 
Syncytial mitochondria are moderately numerous with distinct lamellated 
cristae. The Golgi apparatus is usually well developed. The complexity 
of the syncytiotrophoblast is compounded by the presence of a variety of 
granules, lipid droplets and complex vesicles. Granular ribosomes, 
phagolysosomes, multivesicular bodies and occasional myelin bodies are 
also seen. The syncytial nuclei, with coarsely clumped chromatin and a 
prominent nucleolus, are regularly distributed. The cytotrophoblastic 
cells form a complete layer and have a well-marked cell border; their 
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cytoplasm is less electron dense than that of syncytium and with much 
fewer subcellular organelles. The endoplasmic reticulum is poorly 
developed and does not show vacuolation. Free cytoplasmic ribosomes are 
quite abundant, whilst mitochondria are moderately numerous. There is a 
well-developed Golgi complex and few secretory granules. Lipid droplets 
are rarely present and lysosomal structures are sparse or absent. 
The ultrastructure of the mature villous trophoblast differs from 
that of the immature villi quantitatively rather than qualitatively, and 
its general morphology remains essentially unaltered (Fox, 1978). The 
syncytium is irregularly thinned and the nuclei are often aggregated. 
The microvilli are fewer in number and tend to be shorter and blunter 
than those seen in the immature villi. The syncytial cytoplasm has a 
less complex structure; the endoplasmic reticulum is less abundant, 
whilst lipid droplets, secretory granules, ribosomes and mitochondria 
are less frequently seen. The cytotrophoblastic cells are much less 
prominent and their ultrastructural characteristics are much the same as 
in the first trimester. 
The connecti ve tissue core of the mature villi contains collagen 
fibres, fibroblasts, Hofbauer cells and capillaries. The fibroblasts 
often have elongated processes and their cytoplasm contains an abundance 
of both rough and smooth endoplasmic reticulum, many free ribosomes and 
well-developed Golgi apparatii. The Hofbauer cells are less abundant 
than in the immature villi and have the typical morphological, 
histochemical and functional characteristics of macrophages (Fox and 
Kharkonger, 1969). In the initial stages of gestation the villi are 
avascular and the vessels usually appear by the end of the second month 
of gestation. The lumen of the fetal capillaries is lined by a single 
layer of endothelial cells. 
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The multiple functions of the chorionic villi, including 
transportation and synthesis, is clearly reflected in the morphology of 
the syncytiotrophoblast. Getzowa and Sadowsky (1960), Burgos and 
Rodriguez (1966), and Jones and Fox (1976) were among the first workers 
to assign functions to structurally differentiated areas within the 
syncytiotrophoblast. Experimental evidence which supports the synthetic 
role of the syncytium has come from immunohistochemical studies (Horne, 
lhomson,Bohn 
Towler/and Pugh-Humphreys, 1976; Lin and Halbert, 1976; Currie, Beck, 
Ellis, 
land Read, 1966). 
The total area of the trophoblast surface membrane is clearly an 
important factor in the rate,of exchange of materials between the 
placenta and the maternal circulation. This membrane is normally 
characterized by "turf" microvilli (Hamilton and Hamilton, 1977) which 
must massively increase the effective area of transfer. Conversion of 
the microvillar surface to a relatively smooth surface, which is a 
feature of some pathological processes (Fox, 1967) would much reduce the 
surface area and hence the potential for exchange between the placenta 
and the maternal circulation. 
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1:2 The Syncytiotrophoblastic Microvillous Plasma Membranes 
The microvillous surface membranes of the human syncytiotrophoblast 
represent the major site of contact between the fetus and the maternal 
circulation. It participates in many diverse fUnctions which serve to 
maintain a suitable fetal environment. Nutrients and metabolites are 
exchanged across this surface membrane and it is also involved in 
hormonal and immunological interactions between the mother and the 
fetus. This barrier has long been believed to be involved in the 
failure of maternal rejection of the fetal allograft. While the 
mechanisms of immunological acceptance of the fetus by the maternal host 
during pregnancy remains unclear, many hypotheses involving 
syncytiotrophoblast membrane components have been presented (Billington, 
1979; Wegmann, Singh and Carlson, 1979). Several studies have shown 
that human syncytiotrophoblastic components are sufficiently immunogenic 
when injected into animals to induce the production of antibodies 
showing a high degree of tissue specificity (Beer, Billingham and Yang, 
1972; Behrman, Yoshida, Amano and Paine, 1974). In addition, there 
seems to be a general agreement that these membranes do not express the 
histocompatibility (HLA) antigens, on the basis of failure to detect 
such antigens by immunohistochemistry (Goodfellow, Barnstable, Bodmer, 
Snary and Crumpton, 1976; Faulk and Temple, 1916; Faulk and Johnson, 
1917; McInt'yre and Faulk 1979). However, non-villous trophoblast is 
reported to express HLA A, B, and C antigens, but not the HLA D 
antigen(s) (Sunderland, Redman, and Stirrat, 1981). In addition, the 
villous stroma were found to have HLA-DR positive cells (for review see, 
Redman, 1983). The lack of defined antigens on syncytiotrophoblast 
support the notion that it may be an effective barrier to the maternal 
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immune system. Several workers (Carlson, Wada and Sussman, 1976; 
Ruzycki 
Smith, Nelson, King, DonohueLand Kelley, 1977; Ogbimi, Johnson, Brown 
and FOx, 1979; Ogbimi and Johnson, 1980; Davies, Parry and Sutcliffe, 
1981) have demonstrated that numerous components can be isolated from 
solubilized trophoblast membrane preparations and differences in 
immunological properties reported (Whyte and Loke, 1979). In these 
studies up to 26 major polypeptide bands from a membrane preparation 
were identified by SDS-polyacrylamide gels of which 16 were major 
proteins and 10 glycoproteins. The differences in the number and 
intensity of the bands reported by those investigators are more likely 
to be due to the different solubilization protocols used. Using a 
variety of experimental approaches these proteins can be classified into 
groups according to their sialic acid content, exposure on the external 
surface, tightness of binding to the membrane lipid, and relation to 
membrane structure (Kelley, King, Johnson and Smith, 1979). 
These studies on placental microvillous plasma membranes were 
stimulated by the discovery of Smith, Brush and Luckett (1974), that a 
preparation of microvilli could be obtained by differential 
centrifugation of a saline extract of whole placental tissue. Briefly, 
a fresh term placenta, from which the cord and membranes had been 
removed, was cut into small pieces and washed rapidly in ice-cold 0.11M 
calcium chloride followed by ice-cold physiological saline. This 
removes much of the blood from the intervillous spaces. The washed 
tissue was placed in saline and agitated for 30 min at 40 C using a 
magnetic stirrer. During this procedure, the chorionic villi spread out 
so that their surfaces are well irrigated. The saline was then removed 
and centrifuged at 800g for 10 min to remove fragments of tissue and red 
blood cells. The resulting supernatant was re-centrifuged, first at 
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10,000g for 5 min to remove intracellular debris and then at 100,OOOg 
for 60 min. The resulting pellet, of placental villous surface membrane 
was re-suspended using a tight-fitting glass homogenizer, and washed in 
phosphate buffer saline (PBS) by centrifugation at 100,OOOg for 30m in. 
The justification of this technique was based on electron microscope 
studies, which indicated that the chorionic villous surface was almost 
entirely free of the microvilli after the washing procedure and that 
little or no cellular damage was visible. Using this method, Davies, 
Parry and Sutcliffe (1981) found that the microvilli could be separated 
by sucrose density gradient centrifugation into two populations, which 
showed similar polypeptide patterns on SDS polyacrylamide gels, but 
showed different binding properties for labelled insulin, transferrin 
and IgG. Truman, Wakefield, and Ford (1981) have also reported that two 
fractions of microvilli can be prepared in a similar way. Although 
these two studies involved the use of several membrane markers such as 
5'nucleotidase, placental alkaline phosphatase, IgG receptors, insulin 
receptors and transferrin receptors, the origin of these two fractions 
was not clear. In order to confirm the placental origin of these 
fractions I have used placental alkaline phosphatase as a membrane 
marker. 
These studies on placental microvillous plasma membranes provide a 
base of information which can serve as a reference for further 
investigations into the correlation of the functions of the microvillus 
plasma membrane of the human placenta with protein and glycoprotein 
subunit structure • 
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1:3 Alkaline Phosphatases 
Alkaline phosphatases [orthophosphoric-monoester phosphohydrolase 
(alkaline optimum), EC 3.1.3.1 ] have been studied more than any other 
group of enzymes. A book on alkaline phosphatases (McComb, ~~, 1979) 
lists more than 6,000 references. In man, alkaline phosphatases (APs) 
are enzymes which hydrolyse a wide range of monophosphates and show a 
peculiarly high pH optimum-around 10-10.5. They are present in most 
tissues but have been particularly well studied in liver, bone, kidney, 
intestine and placenta where they show the greatest activities. They 
are glycoproteins which are membrane associated and have been detected 
as cell surface antigens. As we shall see there are at least three 
gene loci coding for the protein moieties of these enzymes. In spite of 
their abundant distribution in nature, including bacteria, plants, and 
animals, the physiological functions of these enzymes remain a mystery. 
1:3.1 Genetic and Biochemical Distinctions Between Human 
Alkaline Phosphatase lsoenzymes 
The hUman alkaline phosphatases (APs) constitute a system of 
multiple molecular forms of enzymes in which heterogeneity is partly due 
to genetic factors and partly to post-translational modifications. The 
number of structural gene loci that code for the different molecular 
forms is unknown. However, at least three gene loci seem to be involved 
in determining the various forms of alkaline phosphatase that occur in 
human tissues : one coding for the placental form, at least one coding 
for intestinal forms (adult and fetal), and at least one coding for the 
liver, bone, and kidney forms (Harris, Hopkinson and Robson, 1974). 
These three classes of APs can be distinguished from one another by 
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their behaviour with certain inhibitors, as well as their 
electrophoretic, immunochemical and thermostability properties (Boyer, 
1963; Robson and Harris, 1967; Stinson and Seargeant, 1981; Seargeant 
and Stinson, 1979; Goldstine, Rogers and Harris, 1980; Lehman, 1975). 
More evidence for the presence of these different classes has come from 
studies on their primary structures (Green and Sussman, 1973; Badger and 
Sussman, 1976). 
Using these criteria the alkaline phosphatases occuring in liver, 
kidney, bone, intestine and placenta from a series of mammals were 
compared with those occuring in human tissues. It was found that in 
each of the animal species studied the liver, bone, kidney and placental 
alkaline phosphatases resembled each other and were distinct from that 
occuring in the intestine. They were also similar to human liver, bone 
and kidney alkaline phosphatases (Goldstine, ~ sj, 1980; Goldstine and 
Harris, 1979). These results suggest the presence of two distinct 
forms of alkaline phosphatase in mammalian species, a liver, bone, 
kidney and placental form which corresponds to human bone, kidney and 
liver isoenzymes and an intestinal form which corresponds to human 
intestinal enzyme. These are presumably coded by two separate gene 
loci. In humans a third distinct form occurs, human placental alkaline 
phosphatase (PAP), coded by an additional gene locus. This was evident 
from starch gel electrophoresis in which PAP was found to be highly 
polymorphic with more than 18 different allelic variants (Donald and 
Robson, 1973). Similar electrophoretic surveys have been carried out on 
the intestinal and other tissue alkaline phosphatases but no such 
allelic variants have been found (Harris, ~.ru., 1974). This implies 
that the mutations affecting the locus for PAP do not affect the other 
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APs which are therefore presumably coded by other loci. 
Some direct evidence for differences in primary structure between 
placental and liver isoenzymes has come from the studies of Green and 
Sussman, (1973) and Badger and Sussman, (1976), in which differences 
were found between their respective N-terminal amino acid sequences, 
two-dimensional tryptic-peptide maps, and their amino acid compositions. 
Differences in the N-terminal amino acid sequences of the liver, 
intestine, and placental isoenzymes were also reported (Badger and 
Sussman, 1976; Komoda, Sakagishi and Sekine, 1981). More structural 
stUdies were carried out on radioiodionated tryptic peptide maps of 
purified preparations of the enzyme forms from liver, kidney, intestine, 
placenta, and serum from a patient with Paget's disease of the bone by 
Seargeant and Stinson (1979). In this study, the fingerprint patterns 
obtaind from liver, bone, and kidney were very similar and can be 
distinguished from those of the intestinal and placental isoenzymes 
which also differ from each other. 
The genetic origin of the alkaline phosphatases that constitute the 
non-placental, non-intestinal group i.e. those from such tissues as 
Ii ver, bone, and kidney remain unclear. These alkaline phosphatases 
differ in electrophoretic mobility and are less heat resistant than 
intestinal and placental alkaline phosphatases (Boyer, 1965; Mulivor, 
Hannig and Harris, 1978; Goldstine and Harris, 1979; Goldstine, ~ sl, 
1980). Their electrophoretic mobilities varied between tissues, but the 
differences in mobility may be accounted for by differences in the 
carbohydrate side chains of the enzymes, as their de-sialated forms have 
identical isoelectric points and similar migration patterns on agar gels 
(Stinson and Seargent, 1981). Furthermore, the phosphatases in this 
group do not differ significantly in catalytic properties, nor in 
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antigenic specificity, as might be expected of the products of distinct 
structural genes. Therefore, a comparison of their properties suggests 
(but does not prove) that bone, liver, and kidney alkaline phosphatases 
are encoded by a single distinct locus and that some tissue-specific 
post-translational variations are introduced during the expression of 
this locus in different types of cells. Evidence from the rare bone 
disease, hypophosphatasia, which is inherited as an autosomal recessive 
(see Harris, 1982), also support the suggestion of a single structural 
gene for these three phosphatases. In one such case, AP activities of 
bone, liver, and kidney were markedly subnormal, whereas activity in the 
small intestine was normal. 
The three main classes of human APs determined by these different 
loci can be sharply distinguished from each other by a variety of 
methods including thermostability, inhibition, immunological, and 
electrophoretic studies. Placental alkaline phosphatase has remarkable 
thermostabili ty (Neale, Clubb, Hotchkis and Posen, 1965; Fishman and 
Ghosh, 1967; Goldstine and Harris, 1979; Stinson and Seargent, 1981). 
It can be heated at 65 0 C for an hour or more without any loss of 
activity. The other APs are destroyed under these conditions. At 560C 
intestinal AP is seen to be much more stable than liver, bone, and 
kidney APs. Table 1 shows the time required to produce 50~ inactivation 
at 56 and 650 C. 
Differential inhibition studies on human alkaline phosphatases by 
certain amino acids and other low molecular weight substances also gives 
good discrimination among these enzymes. The most commonly used 
inhibitors are L-phenylalanine, L-homoarginine , L-phenylalanylglycyl-
glycine, L-leucine, and levamisol. Several reports showed that L-
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phenylalanine strongly inhibits placental and intestinal AP under 
conditions in which liver and bone APs are only slightly inhibited 
(Mulivor, Plotkin and Harris, 1978; Goldstine, ~ £1, 1980; Stinson and 
Seargent, 1981). In contrast, L-homoarginine was found to strongly 
inhibits liver and bone APs but placental and intestinal APs are hardly 
inhibited. Table 2 shows the concentrations of different inhibitors 
required to produce 50% inhibition in the different isoenzymes. 
These isoenzymes were also found to be immunologically distinct. 
Antisera raised against purified PAP usually cross react with intestinal 
AP but show a reaction of only partial identity on o'bhterlony double 
diffusion plates (Boyer, 1965; Lehmann, 1975; 1980). The cross reacting 
antibodies can be absorbed out with intestinal AP leaving antiserum 
monospecific for PAP. These antisera do not cross-react with liver, 
bone, or kidney APs, so one may infer that intestinal AP is more closely 
related immunologically to PAP than is liver, bone, and kidney 
isoenzymes. 
Starch gel electrophoresis of extracts from various tissues have 
shown that all APs have two groups of components. One moves relatively 
rapidly toward the anode and represents the dimeric forms of the enzyme. 
The other migrates relatively slowly. These slow moving components have 
higher molecular weights. The origin of such heterogeneity has been 
discussed mainly in terms of post-translational modification; for 
example, differences in carbohydrate content or formation of enzyme, 
Gunther 
lipid complex (Debroe, Borgers, Wieme, 1975; Doellgast, Spiegel/and 
Fishman, 1977). Recently, other types of heterogeneity have been 
reported such as the occurence of soluble and membrane-bound forms 
(Komoda, ~ 3l, 1981; Colbeau and Maroux, 1978). Treatment with 
neuraminidase results in considerable retardation of the liver, bone, 
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Table 1 Time in minutes required to give 50S inactivation of 
different human APs at 560C (PO) and at 650C (T65) • 
• , , , , , , , , , , , , , , , , , , , , , I , I I I I , , , I , I I , , , 'T56 ' , I , I , I , , , , , , '165 ' I I , , , , , , , I 
Human alkaline phosphatase (minutes) (minutes) 
, ' , • " , " " ", " " , J " , 1 " " , ", 1 1 ", ' " " , " "'" " " , , I !, , '" I !" , ) , 
Liver/bone/kidney 7.4 1.0 
Intestinal >60.0 6.5 
Placental >60.0 
, , , J , , , , , , , , 1 , , , 1 , I , , , • f , , , 1 1 , 1 ' , , I , , I , ! J , , , , 1 ' , , , • , , , , , I , , 1 t , ! , , , , , ! , 
(Adapted from Harris, 1980) 
Table 2 Concentrations of various inhibitors required to produce 50s 
inhibition ([I50] mH), of different human alkaline phosphatases under 
standarized conditions-. 
1 t , " ! ! ,,,,, I , , , , ) " , , " I , , I ' , ) , , , " , " I , , , " l ' , , t , I "" , , , I , , ! , , , , , ! 1 
Phe Har Pgg Leva Leu 
, , , , , , , I , 1 , , , 1 , I ! , , ! , , , , , 1 ' , , , , , , , , , , ! , ! , 1 , , , , , , , , , , , , ) , , , I , , , , , ! , , I , , 
Liver/bone/kidney (AP) 31.0 2.7 30.6 0.03 13.1 
Intestinal (AP) 0.8 40 3.7 6.8 3.6 
Placental (AP) 1.1 >50 0.1 1.7 5.7 
! , , , J , 1 , , I , ! , , 1 • , , , I , , J , , ! , 1 , , ) , 1 , , ! J 1 ' 1 ' , , I , , , ! ' , , , , , , 1 , , , , ' , , , ! , : 1 • , 
*The inhibitors are L-phenylalanine (Phe), L-Homoarginine (Har), 
levamisol (Lev), L-phenylalanylglycylglycine (Pgg) and L-leucine 
(Leu). 
(Adapted from Harris, 1980) 
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and kidney APs. After the treatment their mobilities are essentially 
the same, so the mobility differences they exhibit in the untreated 
state can be largely attributed to differences in sialic acid residues 
(Robinson and Pierce, 1964; Butterworth and Moss, 1966; Moss, Eaton, 
Smith and Whitby, 1966; Mulivor, ~ 21, 1978; Harris 1980). PAP is also 
retarded after neuraminidase treatment though to a lesser extent than 
Ii ver AP. After treatment the various PAP phenotypes remain clearly 
distinct, so the allelic variations are not attributed to the numbers of 
sialic acid residues. The mobility of the adult intestinal AP is not 
altered by neuraminidase. It evidently contains no accessible sialic 
acid residues. In contrast, fetal intestinal AP, which has a greater 
mobili ty than the adult form, is some what retarded by neuraminidase 
(Komoda and Sakagishi, 1978). 
There is now some evidence that there might be a fourth locus in 
man expressed at low levels in testis and thymus, coding for trace 
amounts of heat stable placental-like AP with marked sensitivity to 
inhibi tion with L-Leuc ine (Chang, Angellis and Fishman, 1980; Harris, 
1980; Millan, Eriksson and Stigbrand, 1982). 
1 :3.2 Placental Alkaline Phosphatase Polymorphism 
The existence of a unique gene locus for placental alkaline 
phosphatase (PAP) is evident from the marked allelic variation exhibited 
by this isoenzyme, variation that is not present in other tissue 
alkaline phosphatases. The electrophoretic variations in the enzyme 
extracted from different placentae were first reported by Boyer (1961). 
He described three types of electrophoretic patterns and suggested on 
the basis of their population frequencies that the differences were 
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genetically determined. He also reported the existence of a further 
component, migrating slower than his three bands, which he termed the D-
band. This slow migrating variant was also reported in the studies of 
Beckman and Beckman (1968,1969), as a rare variant, and found to be 
inhibited by L-leucine (Doellgast and Fishman, 1976). Using placentae 
from single and dizygotic twin pairs in the English, Negro and Indian 
populations, Robson and Harris (1965; 1967) confirmed Boyer'S findings 
and described six common phenotypes, refered to as F 1, FlI 1, I1, S 1I 1, 
F1 S 1, and S 1, as well as nine other rare phenotypes, usually in 
combination with one of the common alleles. There is now evidence for 
more than 15 rare alleles (gene frequencies (0.005) beside the three 
common ones (Donald and Robson, 1973; Harris, Hopkinson and Robson, 
1974). In addition, based on population data from different 
investigators, the existence of a "null" allele, .EJ,.Q has been proposed 
(Beckman, Beckman, Christodoulou, and Ifekwunigwe, 1967). The 
nome~lature for the alleles at the AP locus was changed to a simple 
numbering system by Donald and Robson (1973). The former S became 1, F 
became 2 and I became 3. Thus the FS is now 2-1, SI is 3-1 and FI is 3-
2. Rare alleles were numbered from 4 to 18. The frequencies of these 
common phenotypes agreed with the hypothesis that they are determined by 
three common alleles, W (slow mobility), ..EJ,f (fast mobility), and .E.li 
(intermediate mobility). The electrophoretic patterns, in starch gels, 
support this idea since the postulated homozygotes have only one 
principal component whereas the heterozygotes all have three components, 
two in the positions of the product made by the corresponding 
homozygotes, and a third, intermediate in position, which is presumably 
a hybrid molecule since PAP is a homodimer. Gene frequencies of these 
alleles showed a marked variations among various ethnic groups. The £j2 
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allele has its highest frequencies (24-34~) in Caucasian populations, 
whereas lower frequences are found in Asiatic mongoloid groups (2-8~) 
and African Negroes (2-5~). On the other hand, the £13 is comparatively 
common in Chinese and Japanese (20-24~) but low in Caucasians and 
Negroes (4-9%). The Ej1 is the most common in all ethnic groups 
(Beckman and Beckman, 1969; Donald and Robson, 1974). It was proposed 
that these variants are most likely controlled by a series of multiple 
alleles. Twin studies showed that the placental alkaline phosphatase is 
determined by the fetal genotype and not by that of the mother (Robson 
and Harris, 1965). 
There are no differences between these enzyme variants with respect 
to pH-optima, inhibition by L-phenylalanine and L-leucine, and Km values 
towards the tested substrates. However, variations in the 
thermostability between these variants were observed (Holmgren and 
Stigbrand, 1976). Antigenic specificity for the different allelic forms 
was also observed by Wei and Doellgast (1980) using allozyme-absorbed 
antisera. 
The structural differences between the products of the different 
alleles have not been elucidated. Simple amino acid substitutions may 
account for the alleles of PAP, as they do for the Adh~f and Adh,s 
electromorphs of Drosophila alcohol dehydrogenase (Kreitman, 1983). As 
substitutions might involve charged and uncharged amino acids, one would 
not expect the electrophoretic analysis to represent all the possibly 
existing variants. Some evidence for this has come from investigations 
on the potential value of various monoclonal antibodies for the 
detection of the allelic variants of PAP, in which allelic differences 
not detectable electrophoretically have been observed (Slaughter, ~ ~, 
1981; Millan, n.9.1, 1982). 
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To determine the species specificity of PAP, Doellgast and 
Benirschke (1979), used the criteria which distinguish the human 
placental isoenzyme to compare the enzymes in species closely related to 
man. In this study only the chimpanzee and orangutan were found to have 
an isoenzyme resembling that in humans, thus suggesting that the 
occurrence of this isoenzyme is a relatively late event in primate 
evolution. The absence of a similar isoenzyme in lowland gorillas in 
this study was surprising, as there is no evidence for a divergence of 
this species from the line of man's descent after the orangutan. 
Further studies (see Harris, 1980) confirmed these observations and 
suggested that PAP is a relatively recent newcomer on the evolutionary 
scene and appeared subsequent to the divergence of the evolutionary 
lineages leading to man and the great apes from the lineages to most 
other mammalian species including lower apes (e.g. gibbon). 
1:3.3 Synthesis and Molecular Heterogeneity of Placental 
Alkaline Phosphatase During Pregnancy 
Placental alkaline phosphatase becomes detectable in the serum of 
pregnant women between the 16th and the 20th weeks of pregnancy. Its 
levels follow an exponential course, with the highest level occurring at 
delivery in most pregnancies and disappearing within three to six days 
of the delivery. The level during the last trimester of pregnancy 
amounts to 200-300 nglml (Holmgren, Stigbrand and Damber, 1978). No 
correlation has been found between term values of placental isoenzyme 
and placental weight, weight or the sex of the baby, maternal or newborn 
blood type, age or parity of the mother, or the number of the previous 
children (Fishman, m; gl, 1972). The amount of PAP in serum is often 
increased during complications of pregnancy such as hypertension, pre-
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eclampsia, eclampsia and toxaemia (Aleem, 1912; Hunter, ~.s.l, 1910). 
Later studies, on serum levels of PAP, by Holmgren,.m..sl (1978) were 
contradictary to the previous observations. Using a radioimmunoassay, 
their study has shown values of PAP significantly lower than that of 
the mean value for normal pregnancies which were associated with pre-
eclampsia, low weight of the feto-placental unit and intra uterine 
growth retardation. 
In 1916 Fishman, Miyayama, Driscoll and Fishman described isoenzymes 
of alkaline phosphatase in placental tissue that seemed confined only to 
the first 6-10 weeks of pregnancy. These isoenzymes have been called 
developmental phase-specific alkaline phosphatases, early-type, or 
chorionic type phosphatases. Following electrophoresis, early-type 
phosphatases have been shown to consist of two heat sensitive, L-
homoarginine-inhibited bands, the slower band possessing antigenic 
determinants shared with bone and liver phosphatases, whereas the faster 
migrating band lacks any of the known alkaline phosphatase antigenic 
determinants. Phase 2 (11 to 13 weeks) is a mixture of phase 1 and 3 
isozyme components, on starch gels, the latter exhibiting two isozyme 
bands with the characteristics of term PAP, which is now corresponding 
to the A and B forms of PAP. The A form is more anodal and constitutes 
the major zone of enzyme activity in pregnancy serum as well as in 
placental extracts. The B form does not move far from the origin and is 
considered to be a minor component of PAP. Both forms are 
sialoglycoproteins and when treated with neuraminidase showed retarded 
zones of activity on starch gels (Robson and Harris, 1965). The similar 
heat stability and the expression of the same polymorphism in the A and 
B forms of PAP indicates that they contain the same enzymatic 
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polypeptide. The structural basis of the difference between the two 
forms is not known, though the B form appears to be of higher molecular 
weight than the A form. Studies on purified preparations of both forms 
by Ghosh and Fishman (1968) gave molecular weight estimates of 70,000 
and 200,000 for the A and B forms respectively, on the bases of sucrose-
density-gradient ultracentrifugation. The two forms were also reported 
to be interconvertible by storage and dilution, so B-PAP was considered 
to be a molecular aggregate of the A form. In further studies the two 
forms were found to have different isoelectric focusing points and 
behaved differently on acrylamide gel electrophoresis and on ion 
exchange chromatography. The differences in the properties of these two 
enzyme forms were attributed to the association of the B form with 
hydrophobic and basic residues and not to the polymerization of subunits 
alone. On this basis the B form was assumed to be a membrane associated 
form of PAP (Doellgast, ~ sl, 1977). Genetic and structural studies on 
the A form of PAP have shown that the enzyme is a homodimer composed of 
two identical polypeptides. Molecular weight estimates between 63,000-
70,000 were reported for the fully processed form of PAP monomer (Ghosh 
and Fishman, 1968; Holmgren and Stigbrand, 1976; Kelley, ~.9..1, 1979; 
Ogbimi, m:. .9.l, 1979), while an estimate of 61,500 for its precursor, 
synthesized by choricarcinoma cells in vivo, was reported by Ito and 
Chou (1983). 
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1:3.q Tumour-related Alkaline Phosphatases 
It is perhaps significant that fetal proteins are often expressed 
in tumours. The term "oncodevelopmental gene products" has been coined 
for such proteins (Fishman, ~.t il.l, 1968). The ex istence of 
oncodevelopmental gene products such as alphafetoprotein of hepatoma, 
carcino-embryonic antigens of colonic carcinoma as well as several other 
proteins (Wahren, ~ il.l, 1979), suggests that malignancy may involve 
disturbances in the regulation of the expression of genes normally 
active in the embryo and the fetus. Whether most of these proteins are 
tumour-specific antigens or not has yet to be clearly elucidated, as 
detectable levels of these proteins are found in normal human sera and 
in several other tissues (Usategui-Gomez, ~.ru" 19711; Ruoslahti and 
Seppala, 1972; Millan, Eriksson and Stigbrand, 1982). 
Placental alkaline phosphatase was the first enzyme described as an 
oncofetal or carcinoplacental antigen by Fishman, Inglis, Stolbach, and 
Kraut (1968). It was found in the serum of a patient (Mr. Peter Regan) 
with squamous cell carcinoma of the lung. The identity of this enzyme 
with respect to the placental form has not been completely resolved but, 
wi th regard to immunological cross reacti vi ty and similar catalytic 
properties, they seem to be structurally similar (Fishman, ~~, 1968; 
Lehman, 1975). Several years later in Japan, another tumour-related form 
of alkaline phosphatase was found in a patient (Nagao) with pleural 
carcinomatosis (Nakayama, ~ sl, 1970). Although the Nagao isoenz~ is 
indistinguishable from placental isoenzymes immunologically and in some 
biochemical respects (heat inactivation, L-phenylalanine inhibition), it 
is distinct from placental and Regan isoenzymes in terms of its 
sensitivity to L-leucine and EDTA inhibition. With respect to L-leucine 
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inhibition, Inglis, Kirley, Stolbach and Fishman (1973) re-examined 39 
sera known by electrophoretic and catalytic methods to contain the 
ectopically produced Regan isoenzyme, and observed a high incidence of 
sera which exhibited a high degree of L-leucine inhibition, in addition, 
migrated on starch gels to the position of the D-variant placental 
phenotype. On this basis they suggested identity between the rare D-
variant of PAP and the Nagao isoenzyme. This postulation, however, has 
been contested on technical and genetic grounds by Beckman and Beckman 
(1975). Most recent work consider the Nagao isoenzyme to represent re-
expression of a gene structurallty related to but distinct from the 
placental locus (Wei and Doellgast, 1981; Millan, Stigbrand, Ruoslahti 
and Fishman, 1982). 
Placental AP is not the only enzyme expressed during malignant 
transformation : the intestinal type as well as other alkaline 
phosphatases are known to be ectopically expressed in malignant cells 
(Timperley, ~ £1, 1971; Benham, ~ sl, 1978). One such tumour enzyme 
was identified in a patient with hepatoma (Warnock and Reisman, 1969) 
and later named the Kasahara variant. The available data suggest that 
the Kasahara isozyme represents the ectopic expression of the intestinal 
alkaline phosphatase gene ( Higashino, Hashinotsume, Yang, Takah~hi and 
Yamamura, 1972; Higashino, Otani, Kudo and Yamamura 1977; Higashino, 
Kudo, and Yamamura, 1974). This isoenzyme has been also described in 
renal cell carcinomas (Hada, Higashino, Okochi, Yamamura, 1978), 
indicating that the expression of this enzyme is not hepatoma-specific. 
The appearance of alkaline phosphatase with properties similar to 
those of PAP and other tissue APs has been demonstrated in a number of 
HeLa cell lines which were originally derived from a carcinoma of the 
cervix as well as several other celllines derived from various human 
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tumours (Singh, Tsang and Blakemore, 1978; Singer and Fishman, 1974; 
Rutigan ~ sl, 1974). Heterogeneity between HeLa cell-lines for 
alkaline phosphatase expression was observed in a study of eight cell 
lines of HeLa, in which six lines contained placental-like alkaline 
phosphatase, while the others were liver-like and a new form 
distinguishable from all other known isoenzymes (Benham, Povey and 
Harris, 1978). These PAP-like enzymes, although cross reactive with PAP 
when polyclonal antibodies are used, fail to show the clear 
electrophoretic polymorphism of PAP, and can be distinguished 
catalytically by their different pattern of inhibition with L-leu, L-
Leu-Gly-Gly, Phe-Gly-Gly (Millan, Eriksson and Stigbrand, 1983). Thus 
there is question as to the extent of the similarity between these PAP-
like enzymes and the placental enzyme. 
The frequency of detectable concentration of PAP-like isoenzymes in 
screening stUdies of cancer patients falls in a range between 0% 
(Jacoby and Bagshawe, 1972) and almost 100% (Usategui-Gomez ~~, 1974) 
wIth several reported values In the range 5-25% (Lehman, 1975a; 
Stolbach, Kraut and Fishman, 1969). These variations were mainly due to 
the lack of the sensitivity and specificity of the different assays 
employed and to some extent to the origin of the malignancy McLaughlin, 
Gee and Johnson (1983). Although the re-expression of different 
alkaline phosphatases has been documented both in cell lines in vitro 
and in human tumours in vivo, the application of serological assay for 
monitoring malignancy patients has not achieved widespread clinical 
usefulness (Winkleman, Nadler, Demitrian and Pileggi, 1972). Recently a 
highly sensitive and specific solid-phase enzyme immunoassay (EIA) for 
PAP based on the application of monoclonal antibodies (H317) has been 
21 
reported by Mclaughlin ~ £1 (1983), with a detection limit of approxi-
mately 0.07 pgll The use of the H317 monoclonal antibody in solid-phase 
EIA detected measurable levels of circulating PAP-like enzymes in 
significant proportion of ovarian (34%) and cervical (25%) carcinoma 
patients, but did not show detectable levels in other malignancies, 
including breast carcinoma. Thus it may be a useful and sensitive 
serological parameter particularly in ovarian carcinoma. Another 
sensitive immunoassay (sandwich enzyme-linked) has been reported by 
Millan and Stigbrand (1982). Further studies will reveal more clearly 
whether such assays will increase the diagnostic value of alkaline 
phosphatase in cancer. 
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1 : 4 Membrane Proteins 
Since PAP is associated with the syncytiotrophoblastic plasma 
membrane, it is essential to understand the nature of the intimate 
association between such proteins and the membranes. The key to our 
present concept of the structure of membranes was the discovery that 
membrane proteins retain their globular structure and could actually 
span the membrane in an asymmetric fashion. The idea was taken up in 
the "Fluid Mosaic Model", proposed by Singer and Nicolson (1972), which 
attempted to explain this structure in thermodynamic terms and drew two 
conclusions. Firstly, the lipid and protein molecules must be arranged 
in a tightly packed manner in which their hydrophobic regions can 
interact in the core of the membrane whilst the hydrophilic region of 
each amphipathic molecule is exposed to the aqueous environment. The 
second conclusion is that the individual components are free to move 
about in the plane of the membrane with respect to each other. Above 
the melting temperature of the bilayer lipid, the hydrocarbon chains in 
the core of the membrane are in a fluid-like state approaching that of a 
liquid hydrocarbon. This fluidity of biological membranes is a variable 
property which depends on the packing of the hydrocarbon chains of the 
phospholipids. The more tightly packed they are the less fluid is the 
membrane. Although this model is frequently presented as an accurate 
description of membrane structure this is not really the case. It is 
based on the concept that the lipid is the major structural entity in 
membranes, which might be true for myelin membranes which contain only 
25 percent protein by weight, while the plasma membrane and the 
mitochondrial inner membrane contain 50 and 75 percent protein 
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repectively (Houslay and Stanley, 1982), and thus might have a quite 
different structure. A second tenet of the original fluid mosaic model 
is the absence of long range order in the protein molecules. 
Different types of membrane proteins interact with the phospholipid 
bilayer very differently. On this basis membrane proteins can be 
divided into two classes: 
Peripheral membrane proteins: proteins of this class are bound to 
the phospholipid bilayer only indirectly, via a primary interaction with 
another membrane protein. In contrast to integral membrane proteins, 
they can be removed from the membrane by treatments which do not destroy 
the lipid bilayer, such as extraction with salt solutions of low or high 
ionic strength. These proteins, then, are specifically localized to one 
side or another of a cellular membrane. Some such as fibronectin and 
beta-2-microglobulin, are localized to the outer surface of the plasma 
membrane. Others such as spectrin, actin, and other cytoskeletal 
proteins are believed to be synthesized as soluble, cytoplasmic proteins 
which bind to specific proteins (or other molecules) in the membrane 
only after their synthesis. 
Integral membrane proteins : these proteins are firmly embedded in 
the lipid matrix where they exihibit hydrophobic and electrostatic 
interactions with the surrounding lipid. Two key types of experiments 
have established the transmembrane orientation of most of these 
proteins. First, proteolytic digestion of membrane vesicles which 
removes most of the polypeptide backbone, leaving the imbedded portion 
of the protein within the lipid bilayer. Secondly, detergent or 
solvents solubilization which release the intact polypeptide. Because 
of the large number and the varied functions of integral membrane 
proteins, it is unlikely that a single model of interaction with a lipid 
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bilayer will apply to all of them. Lodish, Braell, Schwartz, Strouts 
and Zilberstine (1981) proposed the following classification which 
reflects primarly the differences in interactions of the polypeptide 
chain with the phospholipid matrix. 
A. Transmembrane glycoproteins which span the phospholipid bilayer 
once: this class includes proteins of quite diverse origin (influenza HA 
glycoprotein, erythrocyte glycophorin, the heavy chain of the HLA-A and 
H2 antigens and VSV G protein) and have in common a number of of key 
structural characteristics. All of these polypeptides span the lipid 
bilayer once and in all of them, a region of 10-30 amino acids at the C-
terminus lies within the cytoplasm. Phosphorylated serine residues have 
been reported in the corresponding regions of H2 antigen (Houslay, 
1981) and HLA antigens (Pober, ~ sl, 1978). Adjacent to this region is 
a sequence of 20-25 very hydrophobic amino acids which are believed to 
form be the segment which spans the lipid bilayer. Close to either the 
amino or the carboxy end of this stretch is often a series of lysine and 
arginine residues; possibly this interacts with the phosphate residues 
of the phospholipid bilayer. The remainder of the polypeptide chain 
(which varies in size among these polypeptide species) and its attached 
carbohydrate chains is on the external surface of the membrane. These 
carbohydrate residues may be either N-linked (on asparagine) or O-linked 
(to serine or threonine). The role of these carbohydrates in membrane 
proteins is largely undefined. 
B. Integral membrane proteins which pass through the phospholipid 
bilayer several times: some of these proteins, like rhodopsin and 
erythrocyte band III protein, constitute a major portion of the membrane 
protein in their respective cell types. The striking differences 
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between the configurations of these proteins and those in the previous 
class pose interesting questions as to their mechanism of biosynthesis, 
since in many respects the generally accepted models are inadequate. 
C. Integral membrane proteins which do not span the phospholipid 
bilayer: most of these proteins are enzymes, such as glucose-6-
phosphatase, cytochrome b5, cytochrome b5 reductase , cytochrome P450 as 
well as several glycosyl-transferases. These proteins are anchored to 
the plasma membranes via hydrophobic segments at either their carboxy or 
amino terminals. 
Cells have evolved systems to restrict the mobility of membrane 
proteins in the lipid bilayer to a greater or lesser extent. Specific 
interactions between intrinsic membrane proteins and cytoskeletal 
elements are thought to exist, (Flanagan and Koch, 1978; Koch and Smith, 
1978; Mescher, fi li, 1981; Sheterline and Hopkins, 1981). Controlled 
attachment and detachment of the cytoplasmic portion of integral 
membrane proteins to internal peripheral membrane proteins and 
cytoskeletal elements may occur. The maintenance of such specific 
membrane protein-cytoskeletal interactions may mediate responses to 
intra- and extra cellular stimuli (Houslay, 1981). Such interactions 
could provide a mechanism by which certain types of extracellular 
signals can be transmitted to the interior of the cell. 
There seems to be a general agreement that these transmembrane 
proteins, like most secretory proteins, are synthesized on membrane-
bound polysomes in precursor forms containing, at their amino termini, 
signal peptides, which are sequences of predominantly hydrophobic amino 
acids not present in the mature proteins. The majority of data 
accumulated in this field can be fitted into the "signal hypothesis" 
(Blobel and Dobberstein, 1975) which proposes that a nascent polypeptide 
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destined for export binds to the membrane via the signal sequence. The 
associated ribosomes then forms a complex with membrane proteins, and 
the growing polypeptide chain is extruded through the membrane. The 
signal sequence is proteolytically removed during or immediately after 
the insertion of the nascent polypeptide to generate the mature protein. 
An alternative, the "membrane-trigger hypothesis" (Wickner, 1979), 
envisions a different role for the signal sequence. Here it is proposed 
that the extra amino acids confer a special structure on the precursor, 
which then associates with the membrane. This interaction triggers a 
conformational change resulting in the insertion of the protein into the 
lipid bilayer. This model invokes self assembly whereas the signal 
hypothesis requires the involvement of a protein complex that actively 
translocates the growing chain. A comparison of several signal 
sequences of secretory and membrane integrated proteins of the Vesicular 
Stomatitis virus (VSV) (Lingappa, Katz, Lodish and Blobel, 1978) 
revealed several common features, such as the presence of short amino 
terminal hydrophilic signal followed by a hydrophobic segment of amino 
acids. In 1975 Blobel and Dorbberstein assumed that the microsomal 
membrane could select sequences bearing nascent chains by means of a 
specific receptor. Evidence which confirmed the existance of such a 
receptor has come from studies of Lingappa ~ £1 (1978); Jackson, Walter 
and Blobel (1980); Prehn, Nurnberg and Rapaport (1980), in which 
synthetic signal sequences and other secretory and membrane proteins 
were shown to compete with proteins undergoing translation; and 
translocation could be prevented by inactivating the microsomal 
proteins. This evidence brought into doubt the theory that nascent 
chains alone possessed all the features needed to ensure their transfer 
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through a membrane (Wickner, 1979; Engelman and Steitz, 1981). Over the 
past few years the role played by the microsomes in the interpretation 
of the signal sequence has become better understood. The most recent 
view of the initial events occurring in vectorial transfer indicates the 
participation of two cytoplasmically-disposed proteins. The signal 
recognition protein (SRP) has a molecular weight of 250,000 (Walter and 
Blobel, 1980) and the docking protein (DP) with a molecular weight of 
72,000 (Meyer, Louvard and Dobberstein, 1982). As a nascent secretory 
or membrane protein reveals itself through the exposure of its signal 
sequence, cytoplasmic SRP will recognize it and shut down its fUrther 
translation. This block persists until the nascent chain-SRP-ribosomal 
complex contacts and binds to the endoplasmic reticulum-specific SRP 
receptor, the docking protein. As a result of this SRP-DP interaction, 
the block is removed, translation continues and transfer through the 
membrane commences (for review see Meyer, 1982). 
Although such studies suggest similarities between the structural 
prerequisites for the early events in protein secretion and those of 
membrane assembly, questions regarding the specific mechanism by which 
nascent chains cross the lipid bilayer of the rough endoplasmic 
reticulum have not been answered. 
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CHAPTER 2 
ALKALINE PHOSPHATASE AS A MARKER FOR HUMAN 
PLACENTAL HICROVIu.DUS MEMBRANES 
2: 1 INTRODUCTION 
Human placental alkaline phosphatase is a tissue-specific enzyme of 
the placenta. Histochemical staining indicated that alkaline 
phosphatase is enriched in the syncytiotrophoblastic microvilli (Jones 
and Fox, 1976). One of the common ways of preparing 
syncytiotrophoblastic microvilli is to gently extract the diced or 
minced placenta in saline by the method of Smith ~.al (1974). Using 
this method, Davies, Parry and Sutcliffe (1981) found that the 
microvilli could be separated by sucrose density gradient centrifugation 
into two populations, which showed similar polypeptide patterns on SDS 
polyacrylamide gels, but showed different bindng properties for labelled 
insulin, transferrin and IgG. Truman, Wakefield and Ford (1981) have 
also reported that two fractions of microvilli can be prepared in a 
similar way. In order to confirm the placental origin of these 
fractions of microvilli it was necessary to know if placental alkaline 
phosphatase was present in both. 
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2:2 Materials and Methods 
2:2.1 Materials 
All chemicals for the staining and assay of alkaline phosphatase 
were purchased from the Sigma Chemical Co. Nonidet NP40 was obtained 
from BRL, Rockville, Maryland, U.S.A. Rabbit antisera to human serum 
albumin and human transferrin were purchased from Behring Diagnostics. 
Rabbit antisera to placental microvilli which were rich in anti-
placental alkaline phosphatase were a kind gift of Dr. P.M. Johnson, 
Liverpool University. The antisera were absorbed with adult human serum 
before use. Sepharose CL-6B and DEAE Sepharose CL-6B were obtained from 
Pharmacia (GB) Ltd. Ultrogel ACA 34 was obtained from LKB. 
Placentae were obtained immediately after delivery and were stored 
at 40C and used wi thin 4h. Other tissues were obtained from autopsy 
material within ten hours of death. 
2:2.1 Methods 
1. Plasma Membrane Preparations 
Placental microvilli were prepared by the method of Smith ~ .sl, 
(1974). Washed term placenta1.tissue was diced, placed in 0.16M NaCl, 
agitated for 30 min at 40C, and the 1.0 G supernatant was used as the 
source of microvilli; the residual placental tissue was used as the 
source of "microvillus-depleted placenta". The two fractions of 
microvillous membranes were finally separated by sucrose gradient 
density centrifugation (Davies ~.sl, 1981). 
Plasma membranes were prepared from microvilus-depleted placental 
tissue using the method of Snary, Woods and Crumpton (1976). After 
extraction of microvilli, the microvillus-depleted tissue was passed 
through a specially designed press and the membrane fraction was removed 
by differential centrifugation (Snary ~~, 1976). 
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2. Extraction of Alkaline Phosphatase 
Alkaline phosphatase was prepared from placental and other tissues 
by extraction with butanol/H2O using the method of Boyer (1963) except 
that the incubation time for butanol was increased to 1 h at 200 C in 
order to improve the separation between the aqueous and butanol phases. 
For microvilli, the material was first homogenised in 0.16 M NaCl, 10 mM 
phosphate buffer (pH 7.4) and then extracted against butanol. The 
aqueous phase of the microvillous extract was then aspirated and 
centrifuged (10,000 g for 15 min). These aqueous extractions were used 
for electrophoresis. For gel filtration, the aqueous extracts were 
f11 tered through Whatman No.4 paper. 
To test the effect of other membrane disruption procedures, 
microvilli and homogenates of microvillus-depleted placentae were 
suspended in 0.16 M NaCl, 10 mM phosphate buffer pH 7.4. Aliquots (2 
ml) of these starting materials, containing 1 mg proteinlml were treated 
as follows. For sol vent extraction a 2 ml aliquot was added to 2 ml 
chloroform:methanol::2:1. For detergent extractions, separate al1quots 
were adjusted with nonidet NP40 (to a final concentration of 1%; v/v), 
Na deoxycholate to 0.1 M, or Triton X-100 (0.05-2.0%). In all cases the 
mixtures were vigorously stirred at room temperature for 30 min., before 
centrifugation at 3000 g for 15 min. The aqueous phases were aspirated 
and analysed on starch gels. 
3. Column Chromatography 
Columns of Ultrogel ACA 34 <74 x 5 cm2) and Sepharose CL-6B (24 x 
1.8 cm2) were equilibrated in 4.6 mM tris, 2.5 mM succinic acid, pH 7.0 
with or without the addition of Triton X-100 as stated in the results. 
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Alkaline phosphatase extracts from microvilli and microvillus-depleted 
placenta were applied at room temperature at 20-6 ml/h. The following 
proteins were used for estimation of molecular weight : alpha-2-
macroglobulin (725,000), IgG (150,000), bovine serum albumin (67,000), 
pregnancy associated protein SP3 (mol. wt. 340,000; Horne and Nisbet, 
1979) • 
lJ. Electrophoresis 
Horizontal starch gel electrophoresis was performed according to 
the method of Robson and Harris (1965) as follows: starch gels (12%) 
were made using succinic acid/tris buffer pH 6 (0.0025M succinic acid, 
0.0046M tris) and the bridge solution consisted of a citric acid/sodium 
hydroxide buffer (0.41 M citric acid adjusted to pH 6 usning 10M NaOH). 
Electrophoresis was carried out at 8 V/Cm for 5h in the cold room. 
After electrophoresis, gels were sliced and stained for enzyme activity 
using 8-naphthyl phosphate (25 mg) as substrate in a solution 
consisting of 50 ml borate buffer (0.06 M pH 9.7), 25 mg fast blue RR 
salt and 60 mg MgS04 (Boyer 1961). 
For SDS/polyacrylamide gel electrophoresis (Laemmli, 1970), sample 
preparation and staining was carried out using tris-buffered slab gels 
as described by Sutcliffe ~ .9J. (1980). 
5. Ass a y s 
Alkaline phosphatase was assayed in a system of 62 mM. sodium 
carbonate buffer pH 10.75, 12.5 mM. magnesium chloride, 32.5 mM "Sigma 
104" phosphatase substrate and 5-20 pI. of enzyme solution in a final 
volume of 50 pI. In all assays a control without enzyme and a control 
without substrate were included. The assay solutions were incubated for 
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30-60 min at room temperature. The reactions were then stopped by the 
addition of 0.4M glycine-sodium hydroxide buffer pH 10.3 to a final 
volume of 1 mI. The optical density of the solutions was measured 
spectrophotometrically at 400 nm. The enzyme specific activities were 
calculated by subtracting the sum of the controls from the fUll systems, 
and using the molar extinction coefficient of p-nitrophenol (1.775 X 104 
under these conditions) to express the results in micromoles substrate 
hydrolysed per hour per ml of the enzyme solution (Sutcliffe, Brock, 
Robertson, Scrimgeour and Monaghan, 1972). 
Double immunodiffUsion in 1% agarose was carried out according to 
the method of Ouchterlony (1976). 
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2:3 RES U L T S 
2:3.1 Starch Gel Electrophoresis 
When butanol extracts of either unfractionated placental tissue or 
of microvilli were subjected to starch gel electrophoresis in the 
absence of Triton X-100, the gels (Figure 1a) showed the A and B forms 
of placental alkaline phosphatase as described by Boyer (1963) and 
Robson and Harris (1965). Extracts of microvilli often gave 
considerable smearing of enzyme activity between the A and B bands (see 
Figure 3). However, when Triton X-100 was added to the starch gel at a 
final concentration of 0.5%, alkaline phosphatase from both the total 
placental extract and the placental microvilli showed three bands of 
enzyme activity (Figure 1b). The extra ~and appeared between the A and 
B zones and was particularly prominent in extracts of placental 
microvilli (Figure 1b, Tracks "m"). It was at a very low concentration 
relati ve to the A and B forms in extracts of placentae which had been 
depleted of microvilli (Figure 1b, Track "mdp"). Because the extra band 
of enzyme activity between the A and B forms was at relatively high 
activity in placental microvilli, it has been called placental alkaline 
phosphatase "M". Figure 1c shows that both of the fractions of 
microvillous membrane reported by Davies m; ill (1981) have a small 
amount of the A form, some B form and a preponderance of the M form. 
The method of Smith ~ sl (1974) is for the purification of 
microvilli from the syncytiotrophoblastic brush border. It is a gentle 
method which is not expected to extract the whole plasma membrane of the 
trophoblast. This raised the question of whether some alkaline 
phosphatase A or B might be preferentially located in plasma membrane 
which did not extract under the conditions used by Smith ~ ~ (1974). 
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Accordingly, microvillus-depleted placenta was subjected to disruption 
using the mechanical press method of Snary ~ £j (1976). Plasma 
membranes were harvested in sucrose gradients (Davies ~ gl, 1981), 
extracted with butanol and the enzyme was examined on starch gels. . The 
results (Figure 2) show that the placental plasma membrane (ppm) 
prepared from microvillus-depleted placenta were as enriched in the M 
form as were the microvilli (see Figure 1b, c). In contrast, the A and 
B forms of the enzyme located preferentially in the supernatant 
fraction(s) which overlaid the ppm though, as with the microvilli, some 
was detectable in the membrane preparation. 
Experiments were included to investigate whether the M form of 
placental alkaline phosphatase could be generated during extraction 
through artifactual aggregation of polypeptides at low ionic strength. 
Aliquots of placental microvillous membranes were resuspended in 0.1, 
0.2, 0.3 M NaCl in 10 mM phosphate buffer pH 7.4 and then subjected to 
butanol extraction. The aqueous phases were analysed for alkaline 
phosphatase on starch gels in the presence of 0.5% (v/v) Triton X-100. 
The M form of alkaline phosphatase was prominent in all the aliquots and 
there was no discernable effect of NaCl (Figure 3a). In addition, the 
aqueous phases were analysed in starch gels in the absence of Triton X-
100 (Figure 3b). As expected, no M form was visible in these gels. 
After electrophoresis, the filter paper sample inserts were stained for 
residual enzyme activity and considerable activity was detected (Figure 
3d). No residual activity was detected in inserts from starch gels 
containing Triton X-100 (Fig. 3c). This suggests that a fraction of 
placental alkaline phosphatase requires the detergent to be soluble in 
the starch gel system. This fraction is likely to be the M form since 
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it is absent from starch gels without Triton X-100. Further, the 
finding (Fig. 3a and b) that the quantity of A form in the gel is 
unaffected by Triton X-100 argues that Triton X-100 is not artifactually 
converting A to M (also see results of gel filtration, below). 
The appearance of the M band was unaffected when microvilli were 
extracted not in butanol, but in choloroform:methanol, nonidet NP40, 
sodium deoxycholate, or Triton X-100 (Figure 3e). 
Since the A form of placental alkaline phosphatase is polymorphic, 
the mobility of the M form in extracts of placentae which exhibited the 
different phenotypes of the enzyme polymorphism and their respective 
microvilli were examined. Butanol extracts were made from homogenates 
of whole placental tissue and microvilli and subjected to 
electrophoresis in starch gels containing 0.5% v/v Triton X-100. Bands 
of the M form of placental alkaline phosphatase were observed between 
the A and B bands (Figure 4) and the A form shows the homozygote and 
heterozygote phenotypes 1-1, 1-2 and 2-2, according to the nomenclature 
of Donald and Robson (1974). For each track, the mobility of the M form 
correlated with the mobility of the A form. 
To investigate the immunological cross-reactivity of the different 
forms of placental alkaline phosphatase, pure fractions of A and M and 
butanol extracts of other human organ phosphatases were applied to the 
sample wells of Oochterlony immunodiffusion plates and stained for 
enzyme activity (Figure 5). The results show lines of complete identity 
between A and M-PAP. No reactions were observed with alkaline 
phosphatases from other organs, nor did extracts of other organs 
interfere with the precipitation lines of A and M placental alkaline 
phosphatase. 
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2:3.2 C h rom a tog rap h y 
Molecular weight determinations were performed by molecular sieving 
using Sepharose CL-6B equilibrated in tris-succinate buffer (Figure 6). 
All enzyme activity was eluted in a single peak. Aliquots of the 
filtration fractions labelled 1-12 (Figure 6, upper panel) were subjec-
ted to electrophoresis in starch gels and the results are shown in the 
lower panel of Figure 6, where the M form of the enzyme can be seen to 
elute before the A form. The results (Figure 6) also show that M form 
of the enzyme was co-eluted with alpha-2-macroglobulin (MW 725,000). 
It was necessary to find out whether this high molecular weight 
represents the real molecular weight of the enzyme in microvilli, or 
whether it was an artifact due to the way in which the enzyme had been 
extracted from microvilli and prepared for gel filtration. Gel 
filtration was therefore carried out using AcA 34 in order to find out 
whether the enzyme of lower molecular weight could be generated by 
changing the conditions of enzyme extraction and elution. Ultrogel AcA 
34 was selected as a mixture for gel filtration. It has an exclusion 
limit of 750,000 and a linear range of 20,000-350,000. This choice was 
made in order to detect additional species of sizes between the A 
molecule (127,000) and the species of 725,000. The first experiments 
were designed to determine whether the molecular weight could be 
affected by the presence of Tri ton X-100. Figure 7 shows the elution 
profile of alkaline phosphatase from a column equilibrated in 0.5% 
Triton X-100, tris-succinate buffer. Aliquots of the filtration 
fractions labelled 1-10 (Figure 7, upper panel) were subjected to 
electrophoresis in starch gels and the results are shown in the lower 
panel of Figure 7. In further experiments where Triton X-100 was absent 
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from the gel filtration system, the respective elution patterns of the A 
and the M were the same as in Figure 7. It was also found that the M 
form of the enzyme co-eluted with alpha-2-macroglobulin confirming the 
results of Sepharose CL-6B medium. A fUrther experiment was conducted 
where the gel filtration medium was equilibrated in 0.16 M NaCl, tris-
succinate ~ith9Ut Triton X-100. Here microvilli in 0.16 M NaCI, 10mM K 
phosphate pH 7.5 were extracted with a half volume of butanol, dialysed 
against the equilibration buffer and subjected to gel filtration on AcA 
34. The results showed (Figure 8) that the M form of the enzyme was 
detected co-eluting with alpha-2-macroglobulin, and that there was no 
substantial conversion of the enzyme to smaller species. Experiments 
were also carried out to exclude the possibility that the M form of the 
enzyme is an artifactual hydrophobic aggregate of the A form molecules. 
Enzyme was extracted from microvilli with Triton X-100 instead of 
butanol, before being analysed on AcA 34 equilibrated in 0.16 M NaCl, 
tris-succinate buffer in the presence of 0.5% Triton X-100. No 
conversion of the enzyme to smaller species could be detected. Together 
these gel filtration results show that the presence of Triton X-100 is 
not essential for the detection of a high molecular weight form of 
alkaline phosphatase in butanol extracts of microvillous membrane. 
Placental alkaline phosphatase is more stable at 55-650 C than are 
alkaline phosphatases from other tissues (Neale ~ sl, 1965). The heat 
stability of the A and the M forms of PAP were compared by taking 
fraction numbers 12 and 19, respectively, from the AcA 34 gel filtration 
experiment (Figure 8). Figure 9 shows that the enzyme in both fractions 
remained stable and active for at least for 60 min. at 600 C. For 
comparison, the alkaline phosphatase activity of human male serum was 
almost inactivated after 20 min. at 600 C. 
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Figure 1. The effect of Triton X-100 on the mobility of placental 
alkaline phosphatase in starch gels. 
Starch gel electrophoresis of various extracts of placenta, stained for 
alkaline phosphatase. In (a) the gels did not contain Triton X-100. 
The gels in (b) and (c) contained 0.5% (v/v) Triton X-100. The samples 
applied to the origin (0) were butanol extracts of : total placental 
homogenate (t); microvilli (m); microvillus-depleted placenta (mdp). 
Fig. 1 (c) shows the interface and pellet fractions from the sucrose 
gradient purification of microvilli by the method of Davies ~ gl 
(1981) • 
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Figure 2. The electrophoretic mobility of placental alkaline 
phosphatase after sub-cellular fractionation of 
microvillous-depleted placenta. 
The samples analysed were butanol extracts of the plasma membrane 
fraction (ppm) and the supernatent (s) fraction from a discontinuous 
sucrose gradient. Sample (st) was a butanol extract of microvillus-
depleted placenta which had not been separated on a sucrose gradient. 
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Figure 3. Experiments t o test the effect of various extraction 
systems on the electrophoretic mobility of microvillous 
alkaline phosphatase. 
In figure (a and b) the samples were extracted (see text) into NaCl 
solutions of 0-0.3 M as shown. In Figure (a) the gel contained 0.5% 
(v/v) Triton X-100; in (b) the gel did not contain Triton X-100. Figure 
(c) and (d) show the enzyme activity in sample inserts removed from the 
gel in Figure (a) and (b) respectively, after electrophoresis had 
finished. In Figure (e) microvilli were extracted with 0.1 M Na deoxy-
cholate (DOC); 2: 1: :chloroform :methanol (C/M); 1% (v/v) nonedit (NP40); 
volume of butanol (B); 2% v/v Triton X-100 (TX-100). The extracts were 
loaded onto a starch gel containing 0.5% Triton X-100. 
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Figure 4. The mobility of the M form i n different phenotypes of 
placental alkaline phosphatase. 
Butanol extracts of total placental tissue and placental microvilli were 
applied to starch gels in the presence of 0.5% v/v Triton X-100. The 
phenotypes are noted below each sample. 
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Figure 5. Immunodiffusion plate of the A and H forms of alkaline 
phosphatase. 
Double diffusion of pure samples of PAP forms A and M (A,M) and tissue 
extracts of intestinal (I) liver (L),bone (B), spleen (S), and kidney 
(K) alkaline phosphatase. The antiserum (Ab) is rabbit anti-
microvillous antiserum. The precipitation lines were stained for 
alkaline phosDhatase activity. Equal activities of enzyme were loaded 
in each well. 
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Figure 6. Gel filtration of placental microvillous alkaline 
phosphatase. 
Upper panel: Sepharose CL-6B gel filtration of microvillous alkaline 
phosphatase extracted against butanol. Enzyme activity is plotted 
against elution volume in mI. Aliquots of the fractions marked 1-12 on 
this graph were taken for analysis by starch gel electrophoresis. Lower 
panel: Electrophoresis of aliquots 1-12 in starch gels containing 0.5% 
v/v Triton X-100. The aliquots were loaded according to the numbers 
below the tracks. Sample (st) is an aliquot of the extract originally 
applied to the Sepharose CL-6B column. The gels were stained for 
alkaline phosphatase activity and the origin (0) and the mobilities of 
the A, Band M forms are shown. 
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Figure 7. Gel filtration of placental microvillous alkaline 
phosphatase in the presence of Triton X-l00. 
Upper panel: AcA34 gel filtration of microvillous alkaline phosphatase 
extracted against butanol. Enzyme activity is plotted against elution 
volume in mI. Aliquots of the fractions marked 1-10 in this graph were 
taken for analysis by starch gel electrophoresis. 
Lower panel: Electrophoresis of aliquots 1-10 in starch gels containing 
0.5% v/v Triton X-100. The aliquots were loaded according to the 
numbers below the tracks. Sample (st) is an aliquot of the extract 
originally applied to the AcA 34 column. The gels were stained for 
alkaline phosphatase and the origin (0) and the mobilities of the A, B 
and M forms are shown. 
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Figure 8. Gel filtration of placental microvillous alkaline 
phosphatase in the absence of Triton X-100. 
A butanol extract of microvilli, dialysed against tris-succinate buffer 
(see text), was applied to an AcA 34 column in the absence of Triton X-
100. The enzyme activity was assayed ( •• ) and the elution ranges 
of alpha-2-macroglobulin (a2M) , IgG and human serum albumin (Alb.) were 
determined. The enzyme activity peaks in fraction numbers f12 and f19 
were further analysed on starch gels containing 0.5% v/v Triton X-100. 
and the results are shown in the insert. 
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Figure 9. Heat stability of the A and H forms and of the alkaline 
phosphatase in normal male serum. 
Aliquots of gel filtration fractions number f12 (~~) and f19 
( - - <r- - -v- ) were taken to represent the M and the A forms, respectively. 
Together with a control of serum from an adult male ( ••• ), the 
aliquots were incubated at 600 C for between 10 and 60 min. Samples 
were taken at the various times and assayed for alkaline phosphatase 
activity. The activities were expressed as percentages of the activity 
in unheated reference samples. 
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Figure 10. Summary of observed genetic and non-genetic variation in 
placental alkaline phosphatase. 
The diagram summarises results both by Robson and Harris (1965) and in 
this study, both using starch gel electrophoresis, but differing in 
that the present study employed 0.5% Triton X-100 in the gel. The 
sources of the samples and the phenotypes of the placentae from which 
they came are noted below the diagram : 
m = microvilli, mdp = microvillus-depleted placenta, int = interface and 
pel = pellet of sucrose gradient fractionated microvilli. 
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2:4 DIS C U S S ION 
Though previous biochemical studies have been made on placental 
alkaline phosphatase, this is the first electrophoretic study on enzyme 
extracted from microvilli and it reports a new "M" form of the enzyme. 
Figure 10 summarises the various isotypic and allotypic forms of 
heterogeneity now known for PAP. Although the M form was detected in 
extracts of whole placental tissue which were made according to the 
techniques of previous authors, previous studies did not involve the 
addition of Triton X-100 to starch gels and this step is essential to 
allow the M form to enter the gel and be stained as a descrete band. It 
may be that the failure of Doellgast ~ .9.l (1911) to detect the M form 
in polyacrylamide gels which contained Triton X-100 was due to the 
strength of their gels being too high to permit the M and B forms of the 
enzyme to be resolved. 
2:4.1 Nature Of The H Form 
Various experiments argue that the M form of the enzyme is not an 
artifact. Although Triton X-100 is needed for the detection of the M 
form in starch gels, it cannot be argued that Triton X-100 is creating 
the M form from the A form, since inclusion of Triton X-100 in starch 
gels had no quantitative or qualitative effect on the detection of the A 
form, neither did it generate the M form from purified A form. Instead, 
the effect of Triton X-100 in the starch gel system was found to be that 
it enabled a fraction of PAP to enter the gel instead of remaining at 
the origin, and that this occurred without affecting the detection of 
the A form of the enzyme (Figure 3). The electrophoretic mobility of 
the M form was unaffected when the concentration of NaCl was increased 
45 
during and after the butanol extraction step (Figure 3a). The detection 
of the M form in chloroform-methanol, nonidet, Triton X-lOa and sodium 
deoxycholate extractions argues against it being an artifact of butanol 
extraction (Figure 3e). The molecular weight of the M form 
(approximately 725,000) is unaffected by the inclusion of Triton X-lOa 
or NaC1 in the chromatography buffer. This argues against the M form 
being generated artifactually or as a Triton-enzyme micelle as in the 
case of bacterial membrane carboxypeptidase (Umbreit and Strominger, 
1973). Finally, the possibility that the M form of the enzyme is an 
artifactua1 aggregate, created by hydrophobic protein interactions after 
the membrane lipids had been extracted with butanol was considered. 
Such aggregation phenomena have been found for cytochrome b5 and 
cytochrome b5 reductase, and involve hydrophobic amino acid domains 
whose marked tendency to aggregate in aqueous media can be prevented by 
the addition of detergents (Spa.:)z and Strittmatter, 1971; 1973). It 
was found that extraction of microvilli with Triton X-lOa did not alter 
~ the molecular weight of the M form nor did it alter its characteristic 
mobility in starch gels. 
It is clear that the "M" form of the enzyme is a band of nlacental 
alkaline phosphatase activity, since the M and A forms cross-react 
serologically (Figure 5) and the M form is heat stable at 600 c (Figure 
9). The M band also showed reproducible variation in mobility which 
correlated with the heterozygous and homozygous phenotypes of the A form 
of the enzyme (Figure ij). Taken together, these results indicate that 
the A and the M form share at least part of the same enzymatic 
polypeptide. The results in chapter 3 will also show that purified 
samples of that A and M forms showed a polypeptide of the same molecular 
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weight (69,000), in agreement wi th the findings from previous work on 
the A form by Doellgast ~ sl (1977), Ghosh and Fishman (1968) and 
Gottlieb and Sussman (1968). 
Gel filtration gave estimates of the molecular weight of the A form 
of PAP of 127,000, a values in good agreement with previously published 
data (references quoted above). However, the estimate of the molecular 
weight of the M form by gel filtration gave a much greater MW value of 
725,000. These estimates from gel filtration were unaffected by the 
presence of 0.16 M NaCl or 0.5% Triton X-100 in the membrane extraction 
or in the filtration system. The results in this chapter show that this 
discrepancy between the gel filtration and the electrophoresis is 
unlikely to be due to an experimental artifact. It may be that the M 
form is composed of either an aggregate of 5 or 6 A form molecules, or a 
lesser number of molecules with other material. Both these types of 
possibilities have been raised by Doellgast ~ 21 (1977) in an attempt 
to examine the structure of the B form of alkaline phosphatase, which in 
their hands had a molecular weight of over 200,000. A fuller analysis 
of the biochemical composition of the A, and M forms of PAP will be 
disrcussed in the following chapters. 
'V 
2:~.2 L 0 cat Ion 
Carlson ~ 21 (1976) were among the first to show biochemically 
that placental plasma membrane fractions are enriched in alkaline 
phosphatase. The present results indicate that the placental alkaline 
phosphatase associated with the microvillous plasma membrane is enriched 
in an "M" form of the enzyme. Further, the M form is equally 
represented in both the sub-fractions of placental microvilli which were 
described by Davies ~ £1 (1981) and by Truman ~ £1 (1981). The A form 
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of the enzyme is found predominantly in other parts of the placenta, 
though still presumably in the syncytiotrophoblastic cells, since 
alkaline phosphatase has been detected histochemically in the 
syncytiotrophoblast alone (Jones and Fox, 1976). The B form of the 
enzyme was found in both microvillous and non-microvillous material, but 
its concentration was not high enough to show if it had a preferential 
location. Evidence was sought that some of the A and B forms of the 
enzyme might be located in a fraction of trophoblast plasma which was 
not extractable by the method of Smith ~.s.l (1974). However; when a 
more severe form of extraction (due to Snary ~ sl, 1976) was used after 
the removal of microvilli, the resultant plasma membranes were rich in M 
and showed as little of A and B as did the microvillous fraction (Figure 
2). Thus no evidence could be found for a sub-fraction of trophoblast 
membrane which was enriched in enzyme other than the M form. It is 
worthnoting that the amounts of the A and B forms which can be seen in 
the microvillous preparations vary (Fig. 3) and can be washed off these 
membranes by phosphate buffered saline (Fig. 4). 
2:4.3 Some Implications 
In the absence of knowledge about the biological function of 
placental alkaline phosphatase, the functional implications of the 
presence of the M form of the enzyme in microvilli is quite unclear. 
However, the finding of the M form has some potential clinical 
significance. The concentration of PAP in maternal serum increases as 
pregnancy proceeds, suggesting that the enzyme could be of clinical use 
in monitoring or predicting complications of pragnancy which involve 
alterations in placental function, such as pre-eclampsia and placental 
insufficiency. Although the results of investigations into this have 
48 
proven sufficiently discouraging that the enzyme assay is now hardly 
ever used in clinical obstetrics, these studies did not take account of 
the molecular heterogeneity of the enzyme described in this study. 
Clearly, many factors affect the concentration of the enzyme in 
maternal blood. These include maternal blood volume, maternal enzyme 
clearance rates and the size and functional status of the placenta. 
Further, the enzyme may enter the serum from the syncytiotrophoblast in 
any of at least three general ways: (a) secretion, (b) rupture of the 
syncytiotrophoblast and loss of cytoplasmic contents and (c) shedding of 
microvilli. It is not known whether alkaline phosphatase is actively 
secreted into the maternal blood. The findings of syncytiotrophoblastic 
fragments and fetal blood cells in the maternal circulation suggests 
that route (b) may contribute to maternal serum alkaline phoshatase. 
The knowledge that microvilli can readily be washed from the term 
placenta suggests that membrane loss can also occur during pregnancy. 
It is possible that the rate of such a loss could affect the transport 
capacity of the placenta, and that the extent of this loss might be 
estimated by measuring the serum level of the M form of PAP. 
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CHAPTER 3 
PURIFICATION AND CHARACTERIZATION OF 
MICROVIllOUS ALKAUNE PHOSPHATASE 
3:1 I N T ROD U C T ION 
Human placental alkaline phosphatase (PAP) is a marker of 
syncytiotrophoblastic microvillous membranes (Carlson, Wada and Sussman 
1976). Genetic and structural studies on the A isotype of PAP (A-PAP) 
have shown that the enzyme is a homodimer composed of two identical 
polypeptides of molecular weight 70,000 (Robson and Harris 1967, Ghosh 
and Fishman 1968). The B-PAP has a molecular weight of over 200,000 and 
was considered by Ghosh and Fishman (1968) to be a molecular aggregate 
of A-PAP. Later studies by Doellgast ~ sl (1977) suggested that B-PAP 
results from the polymerization of A-PAP with other material. The 
results in chapter 2 (Abu-Hasan ~..9.l, 1984) have shown that the major 
form of PAP in syncytiotrophoblastic microvillous membranes has a native 
molecular weight of 725,000, which is much higher than that reported 
for A-PAP and B-PAP. This microvillous form of PAP was termed M-PAP and 
has a mobility between the A and B forms in starch/Tri ton X-1 00 gels. 
AntigeniC, polymorphic and heat stability stUdies showed that all three 
forms of PAP share a common polypeptide, though it is not known whether 
M-PAP also contains other materials. Since Triton X-100 was necessary 
for M-PAP to enter starch gels, Abu-Hasan ~ sl (1984) suggested that M-
PAP was substantially more hydrophobic than either A-PAP or B-PAP. The 
present data reports the purification of M-PAP and subsequent structural 
and kinetic comparisons with A-PAP. 
50 
3:2 MATERIALS AND METHODS 
3:2.1 Materials 
iodoacetam ide 
Iodoacetic aCid,' di thiothreitol, Cyanogen bromide (CNBr) and all 
chemicals for the staining and assay of alkaline phosphatase were 
purchased from the Sigma Co. Isoelectric point markers, Amberlite 
Monobed Resin and iodoaceamide were purchased from BDH Co. Hydrophobic 
chromatography (Agarose C n series) were obtained from Miles Co. 
Ampholines were obtained from LKB. DEAE Sepharose CL-6B was obtained 
from Pharmacia (GB) Ltd. Placentae were obtained immediately after 
delivery and were stored at 40 C and used within 4 hours. 
3:2.2 Methods 
1. Preparation and Extraction of Microvilli 
Placental microvilli were prepared as a 1 G supernatant by the 
method of Smith, Brush and Luckett (1974). Alkaline phosphatase was 
prepared from placental tissue by extraction with butanol/H2O using the 
method of Boyer (1963) except that the inCUbation time for butanol was 
increased to 1 h at 200 C in order to improve the separation between the 
aqueous and butanol phases. Extraction of microvilli, was carried out 
as described in chapter 2. 
2. Column Chromatography 
A column of DEAE Sepharose CL-6B (2.5 x 25 cm) was equilibrated 
with tris-succinate in the presence of 0.5% Triton X-100, pH 7.0 
(equilibration buffer). Butanol extracts of alkaline phosphatase 
prepared from microvilli of 7 heterozygous placentae were made up with 
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glycerol to 5.0~ (v/v) and Triton X-100 to 0.5~ (v/v). The material was 
passed through the column at 150 ml/h in equilibration buffer and was 
eluted at 20 ml/h with a linear gradient of 400 ml of equilibration 
buffer containing a linear gradient of O-O.5M NaCl at room temperature. 
3. Electrophoresis 
Horizontal starch gel electrophoresis at pH 6.0 ( Robson and Harris 
1965) was performed as described in chapter 2 (Abu-Hasan ~~, 1984). 
Non-dissociating polyacrylamide gel electrophoresis in both tubes and 
slabs was carried out using 7% (w/v) polyacrylamide gels made by the 
method of Ryrie (1975) with the modification that Triton X-100 was added 
to the gel to a final concentration of 0.5~ (v/v). Gels were stained 
for alkaline phosphatase activity and also for protein using Coomassie 
blue. 
SDS/polyacrylamide gel electrophoresis (Laemmli, 1970), sample 
preparation and staining was carried out using tris-buffered slab gels 
as described by Sutcliffe .ru; ~ (1980). 
4. Reduction and Alkylation 
Acetone precipitates of pure fractions of the A and M forms of the 
enzyme were dissolved at 1mg/ml in 10M urea. Reduction was carried out 
by adding 1/5 volume of a solution of 36 mM dithiothreitol/0.8M 
urea/0.24M Tris-HCl, pH 8.4. This was incubated at 370 C for 30 min and 
then made up to 0.1M with respect to iodoacetamide/iodoacetic acid. 
Varying the proportions of these two reagents can be used to titrate 
cysteine residues (Mossman and Williamson, 1980). Incubation was 
continued for 30 min and terminated by the addition of 5 vol. of 
acetone. The reduced and alkylated samples were recovered as a 
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precipitate after centrifugation at 5000 g and were resuspended in 
freshly deionised 10 M urea. 
5. lsoelectric Focusing 
Thin layer plates of polyacrylamide gel, 5 x 10 x O.lcm, were 
prepared by the polymerization of degassed 5% (v/v) acrylamide deionized 
with Amberlite Monobed Resin (BDH) containing 21 (w/v) Ampholine carrier 
ampholi tes (pH 3.5-10.0) and freshly deionized 8M urea. The gel was 
polymerised with 10% ammonium persulphate, stood at 40 C for 15 min. 
before one glass plate was carefully removed from the gel. Protein 
samples were loaded on Whatman 3mm filter paper. The cathodal and 
anodal buffers were I M solutions of NaOH and H3 P04 respectively, and 
isoelectric focusing was carried out over a water-cooled platter at an 
ini tial current of 30 rnA for a period of 3-4 h. After focusing, the 
gels were washed in several changes of 12.5% (w/v) trichloracetic acid, 
3.5% sulphosalicylic acid for 5-8 h. This was followed by a 30 min 
wash in destain (methanol/water/acetic acid in the ratio of 5:4:1) 
before staining in 0.25% coomassie blue desolved in destain. The pH 
gradient was determined using LDH protein markers, range pH 4.7-10.6. 
6. Cyanogen Bromide (CNBr) Fragmentation of Proteins 
CNBr degradation at low pH was carried out as using a modification 
of the acidic acetonitrile method of Nikodem and Frisco (1979) as 
follows. Cyanogen bromide (225-250mg) was dissolved in acetonitrile (100 
pI) to a final volume of 150 pI, an aliquot (20 pI) of this reagent was 
aded to each sample of protein (25-30 pg in 50 pI), followed by 200 pI 
of 0.6 N HCl. The mixture of cyanogen bromide and protein was left at 
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room temperature for 90 min. The reaction was then terminated by drying 
the sample under low pressure vacume. As a control, the cyanogen 
bromide was omitted and a solution of acetonitrile and Hel was aded to 
the protein. 
7. Hydrophobic Chromatography 
A small column of 1.0 ml of alkyl agarose (Miles) was equilibrated 
with tris-succinate buffer pH 7.~. An aliquot of dialysed butanol 
extract of microvillous membranes was passed through the column at 6ml/h 
and O.~ ml fractions were collected. The column was then washed in the 
equilibration buffer and the bound protein was eluted with 10% butanol 
in tris-succinate buffer, pH 7.~ (see above). The fractions were 
assayed for enzyme activity and analysed on starch gels containing 0.5% 
(v/v) Triton X-lOO. 
8. Ass a y s 
Protein was estimated by the method of Lowry ~ .s.l (1951) using 
bovine serum albumin as standard. For those fractions containing Triton 
X-100, the modification of BonsaI' and Hunt (1971) was used, in which 
SDS was added to prevent the formation of water-insoluble complexes 
between phosphomolybdate and Triton X-100. Alkaline phosphatase was 
assayed in a system of 62 mM. sodium carbonate buffer pH 10.75, 12.5 mM. 
magnesium chloride, 32.5 mM. p-nitrophenol as substrate and 5-20 pI of 
enzyme in a final volume of 50 Jll (Sutcliffe, Brock, Robertson, 
Scrimgeour and Monaghan, 1972). Albumin and transferrin were assayed by 
antibody-antigen crossed electrophoresis (Laurell) as described by 
Sutcliffe ~.al (1980). 
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3:3 RES U L T S 
3: 3. 1 Ion-exchange Chromatography 
To study the polypeptide composition of the enzymes, alkaline 
phosphatase was extracted with butanol from the microvilli of seven 
placentae and subjected to ion-exchange chromatography in the presence 
of Triton X-100. The results (Figure 1) show that some protein did not 
bind to the column and that four discrete peaks of protein were eluted 
with the salt gradient between O.04M and O.15M NaCI. Alkaline 
phosphatase activity was found to elute from the column in two peaks, at 
O.04M and O.lM NaCl, which correspond to the first and third eluted 
peaks of protein. When transferrin and serum albumin were assayed in 
the fractions by antibody-antigen crossed electrophoresis, the proteins 
were detected at positions corresponding, respectively, to the second 
and fourth eluted peaks of protein (Figure 1). Aliquots of the 
fractions labelled 48-61 were taken and studied by electrophoresis in 
starch gels containing 0.5% (v/v) Triton X-l00. The results in the 
lower panel of Figure 1, show that M-PAP eluted at 0.04M NaCl and that 
A-PAP eluted at 0.1 M NaCl. The B form of the enzyme eluted close to 
M-PAP but was present at a much lower activity. 
3:3.2 Polyacrylamide Gel Electrophoresis 
The purity of the alkaline phosphatase in the two eluted peaks of 
enzyme activity (cf. Figure 1) was assayed in non-denaturing 
polyacrylamide gels (Ryrie, 1975) stained either for enzyme activity or 
with Coomassie blue. Figure 2 shows the results obtained with gels, 
some of which contained 0.5% (v/v) Triton X-100. With 0.5% (v/v) Triton 
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X-100 in the gel, two zones of enzyme activity were observed in 
fractions 49-51 (Tracks 1-3; Figure 2) whilst fractions 59-61 showed a 
single band of alkaline phosphatase of faster mobility (Figure 2). 
When stained with Coomassie blue (Tracks 4 - 6 and 8), bands of protein 
staining were observed which correspond to the bands of enzyme activity. 
The main conclusion from this experiment was that a substantial 
purification of alkaline phosphatase had been affected. However, the 
finding of three bands of enzyme activity in the polyacrylamide gels 
(with Triton X-l00) prompted the Question of whether there was a simple 
correspondance between these bands and the A, Band M forms of PAP. 
Since fractions 59-61 showed mainly the A form of the enzyme in starch 
gels (Figure 1, lower panel), the most anodal band of enzyme activity 
in polyacrylamide/Triton X-100 gels (Figure 2, Track 7) corresponds to 
the A form of the enzyme. A very strong band of intermediate mobility 
was observed when a butanol extract of microvilli was run in 
polyacrylamide in the presence of 0.5% Triton X-100 (Figure 2, Track 
16). Since the bands of slower and faster mobility stain more weakly, 
the fast band was deduced to be A-PAP and the strong intermediate band 
is M-PAP. The identity of the slowest band is not clear. Tracks 1-3 
show approximately equally intense staining for both cathodal bands and, 
since starch gels show an excess of M-PAP over B-PAP in fractions 49-52, 
we cannot at present consider that the slowest mobility form is B-PAP. 
The extent of the separation of the cathodal two bands of alkaline 
phosphatase depended on the conditions of electrophoresis. Omission of 
Triton X-100 from the gel led to the enzymes being found at or around 
the origin (Figure 2, Tracks 9 -15), with only the A form entering the 
gel. In the presence of the detergent, the two bands could be resolved 
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in gels up to 7% acrylamide. In 10% acrylamide they had virtually the 
same mobility and were difficult to distinguish. 
The ion-exchange fractions containing alkaline phosphatase were 
analysed on SDS/polyacrylamide gels (figure 3). In the presence of 
reducing agents, a single protein band was observed which had the same 
mobility in the fractions containing the M (tracks 1-6 and 14) and A 
(tracks 11-13) forms of the enzyme. Fractions 54-57 of the ion-
exchange elution contained transferrin (Figure 1, upper panel; Tf) and 
a protein band of the mobility of transferrin was observed in the SDS 
gel (Figure 3, Tracks 7-10). 
Aliquots of pure fractions of A-PAP and M-PAP and butanol extracts 
of microvillous membranes were lyophylysed and incubated without 
reduction in different concentrations of urea at room temperature, 
before SDS/polyacrylamide gel electrophoresis. The results (Figure 4, 
tracks 4,5,6, and 7) show aliquots of M-PAP incubated for 2 h in 10% 
SDS, 3M, 5M and 8M urea respectively. A doublet band occurred at 
approximately l16K and two minor bands of mobilities corresponding to 
180K and 69K could also be seen. Further incubation of these samples 
for up to 48 h under the same conditions showed no detectable 
differences either in the mobility or in the intensity. Tracks 8 and 
9 show aliquots of A-PAP incubated for 2 h in 8M and 5M urea 
respectively. They show a major band with a mobility corresponding to 
130K and a minor band at 69K. Track 2 shows the behaviour of the 
butanol extracts incubated in 8M urea for 2 h, in which bands of 
mobilities corresponding to 180K, 130K, 116K and 69K can be seen. 
Tracks 1, 3 and 10 show the reduced butanol extracts, M-PAP and A-PAP 
respecti vely. All these samples show a band at 69K. 
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3:3.3 Reduction, Alkylation and Isoelectric Focusing 
Reduced and alkylated A and M-PAP were compared in 8M urea in thin 
layer polyacrylamide isoelectric focusing gels of pH range 3.5-10. 
Figure 5 shows the patterns obtained. Multiple isoelectric bands were 
present in both forms under different alkylating conditions, but there 
were some bands of relativly high pI which were observed in M-PAP, but 
not in A-PAP. Preparations of M-PAP were also found to cause distortion 
to the surface of the gel, mainly at the high pI region. Regions of 
distortion are indicated by arrows. The considerable similarity between 
the banding patterns of the A and M forms remained whether alkylation 
was carried out with iodoacetamide, iodoacetic acid or a mixture of 
both. In those preparations alkylated with iodoacetamide, several 
isoelectric bands were observed between pH 5.65-5.95 (tracks 4,5). With 
iodoacetic acid, a lesser number of bands of pI 5.15-5.3 were observed 
(tracks 2,3). With a mixture of iodoacetic acid and iodoacetamide (5:1) 
both forms produced similar band numbers to those samples alkylated 
with iodoacetamide with pI values ranging between 5.15 and 5.65 (tracks 
6,7). There were more clearly defined bands in preparations of A-PAP 
(tracks 2,4,6) than the M-PAP (tracks 3,5,7), though incorporation of 4% 
Nonedit NP40 into the isoelectric focusing system somewhat improved the 
resolution of M-PAP. 
3:3.4 Cyanogen Bromide (CNBr) Fragmentation of PAP 
Pure fractions of M and A-PAP were compared by CNBr fragmentation. 
The results (Fig. 6 tracks 1,2,3 and 4) show a very similar methionine 
cleavage patterns in both polypeptides. The controls for this 
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experiment included samples of A-PAP, M-PAP and BSA without treatment 
with CNBr (tracks 6,7 and 8 respectively). Also included was a sample 
of BSA cleaved in the presence of CNBr (track 5). 
3:3.5 Hydrophobic Chromatography 
A comparison of the hydrophobicity of the different forms of 
placental alkaline phosphatase was made by investigating their 
affinities for hydrocarbon-coated agaroses that varied in the length of 
their alkyl side chains up to a length of Cl0. The columns differed in 
their ability to bind the enzyme. Un-alkylated agarose (Miles type 
"c=o") did not bind either form of the enzyme. C 6 alkyl chains 
(Miles type "C=6") bound the A, Band M-PAP. Figure 7 shows the 
isozymes of PAP in the excluded and eluted fractions from a C2 column 
loaded to its exclusion point with butanol extracts of microvillus 
membranes. Figure 7 (a) shows the starting material (st) and the 
electrophoretic pattern of the enzyme which failed to bind to the 
column. In the early fractions (1-5) the M band is absent, though some 
M-PAP can be seen in later fractions, perhaps due to saturation of the 
column. When the bound enzyme was eluted with 10% butanol solution, 
the eluted fractions showed only M-PAP (Figure 7 b). 
3:3.6 Enzyme Kinetics 
Michaelis constants (Figure 8) and pH optima (Figure 9) were 
determined for purified M-PAP and A-PAP, obtained from the gel 
filtration of butanol extracts of microvilli. As shown in table 1, A-PAP 
and M-PAP had very similar pH optima, namely mean values of 10.8 and 
10.9, respectively. The Km values were also comparable, having means of 
3.89 (mM) and 3.66 (mM) for the A and M forms, respectively. 
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TABLE 1 Km values and pH optima for A-PAP and M-PAP, showing 
means* and ranges. 
Enzyme Km (roM) pH optimum 
A-PAP 3.89 10.8 
(3.2-4.4) (10.7-11.1) 
M-PAP 3.66 10.9 
(3.2-4.0) (10.7-11.2) 
*calculated from 5 determinations 
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Figure 1. Ion-exchange chromatography of placental microvillous 
alkaline phosphatase in the presence of 0.51 Triton X-100. 
Upper panel: DEAE Sepharose CL-6B chromatography of alkaline phosphatase 
extracted with butanol from placental microvilli. Enzyme activity, 
protein concentration and the concentration of NaCl are plotted against 
elution volume in mI. The horizontal bars represent the elution volume 
of transferrin (Tf) and albumin (Alb), detected by antibody-antigen 
crossed electrophoresis. Aliquots of the fractions marked 48-61 were 
taken for analysis by starch gel electrophoresis. 
Lower panel: Electrophoresis of aliquots 48-61 in starch gels containing 
0.5% (v/v) Triton X-100. The aliquots were loaded according to the 
numbers below the tracks. Sample "St" is an aliquot of the butanol 
extract originally applied to the ion-exchange column. 
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Figure 2. Analysis of fractions from ion-exchange chromatography in 
non-denaturing polyacrylamide gels. 
Polyacrylamide gels (7%), some containing (+) and others lacking (-) 
0.5% Triton X-100, were loaded with samples from the ion-exchange 
fractions (identified below each track) and with butanol extracts of 
microvilli (m). The gels were stained for either enzyme activity or 
protein as indicated below the tracks. The origin is at the cathode. 
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Figure 3. Analysis of fractions from ion-exchange Chromatography in 
SDS/polyacrylamide gels. 
SDS/polyacrylamide gels (4.5-12%) were used to analyse the protein in the 
butanol/H20 extract of microvilli which was applied to the ion-exchange 
column (sample "St", Track15 and. Tracks 1-14, show various fractions 
(identified below the tracks) after treatment with a-mercaptoethanol. The 
origin is at the cathode. The molecular weight calibration is provided 
from standard proteins run in adjacent tracks. 
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Figure 4. Analysis of A-PAP and H-PAP in 50S gels without reduction. 
Before electrophoresis, aliquots of A-PAP, M-PAP and butanol extracts of 
microvillus membranes were incubated for 2h either in SDS or in 
different concentrations of urea. In tracks 4,5,6,7 M-PAP was incubated 
in 10% SDS, or in 3M, 5M, and 8M urea, respectively. Aliquots of A-PAP 
(tracks 8,9) were incubated in 5M and 8M urea, respectively. Track 2 
shows an aliquot of butanol extract incubated in 8M urea. Tracks 1,3,10 
show reduced samples of butanol extract, M-PAP and A-PAP, respectively. 
pH 2345 67 
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Figure 5. Isoelectric focussing of reduced and alkylated PAP. 
Reduced and alkylated A-PAP and M-PAP were resolved in a pH gradient of 
3.5-10.0 in 8M urea/polyacrylamide gels. Aliquots of acetone-precipi-
tated preparations of purified A-PAP (tracks 2,4,6) and M-PAP (tracks 
3,5,7) were reduced with dithiotreitol and alkylated with iodoacetate 
(tracks 2,3), iodoacetamide (tracks 4,5), or a 5:1 molar ratio of 
iodoacetate : iodoacetamide (tracks 6,7). Track 1 contains pH markers. 
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Figure 6. 50S gel analysis of CNBr peptides from purified preparations 
of H and A-PAP. 
Aliquots of purified M and A-PAP were cleaved in acidic CNBr (denoted as 
'-' below tracks). Tracks 1 and 2 contain cleaved A-PAP, tracks 3 and 4 
contain cleaved M-PAP. Track 5 contains cleaved BSA. Cleavage controls 
of A-PAP, M-PAP and bovine serum albumin (alb.) are shown in tracks 6,7 
and 8 respectively ('-' shows were CNBr was omitted from the reaction). 
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Figure 7. Hydrophobic affinity chromatography of PAP on a C2 agarose 
coltlll1. 
A C2 agarose column was loaded with a butanol extract of microvillus 
membranes (samples "st"). The excluded enzyme fractions (gel a) and the 
bound enzyme (gel b) were analysed in starch gel electrophoresis. 
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Figure 8. The effect of substrate concentration on the activities of 
the A and H fonns of PAP. 
Lineweaver-Bruk plots for the A and M forms of placental alkaline 
phosphatase. The velocity (v) is expressed as mp mole of p-nitrophenol 
phosphate converted / pI in 30 min at 370 C. 
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Figure 9. The effect of pH on the activities of the A and H forms of 
placental alkaline phosphatase. 
Aliquots of purified M and A-PAP were assayed at different pH values. 
The pH-activity curves for the A and M forms of PAP with 32.5 mM p-
ni trophenol phosphate as substrate were plotted. Enzyme acti vi ty is 
expressed as mp moles of substrate converted / pI in 30 min at 37°C. 
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Figure 10. The effect of reduction on the mobility of bovine serum 
albumin in SDS/polyacrylamide electrophoresis 
Bovine serum albumin (20 pg per track) was prepared for SDS 
polyacrylamide gel electrophoresis according to the materials and 
methods, except thatB -mercaptoethanol was added to the protein applied 
to tracks 1-3. The protein applied to tracks 5-7 had not been treated 
B-mercaptoethanol. Track no. 4 contains molecular weight markers. 
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3:4 DIS C U S S ION 
The finding that A-PAP and M-PAP have similar pH optima and Km 
values (Table 1) is consistent with the previous findings in chapter 2 
(Abu-Hasan ~ sl, 1984) that both forms are heat-stable, that they share 
antigenic determinants and exhibit the same genetic polymorphism. 
Studies on the polypeptide composition of A-PAP and M-PAP under reducing 
conditions in SDS/polyacrylamide gels showed that both forms contained 
a similar polypeptide subunit of 69,000 molecular weight. The 
molecular weights of the A-PAP subunit and of its dimer 130,000 are in 
good agreement with the previous results of Ghosh and Fishman (1968), 
Gottlieb and Sussman (1968), Sussman~li (1968), and Doellgast~.s.l 
(1977). M-PAP also contains a disulphide-bonded dimer, though the 
mobili ty of the protein in SDS/polyacrylamide gels in the absence of 
reduction (116,000) is less than for the dimer of A-PAP. Since both 
forms have the same molecular weight of polypeptide under reducing 
conditions, the difference between the 116,000 and 130,000 bands cannot 
be due to proteolysis. An alternative explanation is that the dimers 
of A and M-PAP differ in their conformation and hence in their rates of 
migration in the SDS gel. Since the disparity in the molecular weight 
of A and M-PAP is only seen in the absence of reduction, it may be due 
to differences in the pattern of inter- or intra-domain disulphide 
bonding in the two forms. That this is a feaSible possibility is 
illustrated in Figure 10, which shows that the mobility of serum albumin 
is increased under non-reducing conditions, presumably because the un-
reduced protein is in a more compact state. It was also observed that 
in the absence of reduction the M-PAP dimer showed two polypeptide 
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species within the 116,000 band (Figure 4). These two species appear 
to be components of M-PAP, since the samples analysed were substantially 
free of B-PAP and .A-PAP. 
Isoelectric focusing of reduced and alkylated PAP polypeptides 
revealed bands in common between the two isoenzymes. The charge 
heterogeneity in these bands could be due to in vivo modifications such 
as phosphorylation or addi tion of charged carbohydrate groups, or it 
could be due to artifactual modifications induced during the reduction 
and alkylation procedures. The most likely targets for such 
modifications are cysteine, asparagine, and glutamine. Cysteine can be 
readily oxidized to form cysteic acid while asparagine and glutamine are 
known to undergo spontaneous deamidation (0' Farrell, 1975). The 
considerable similarity between the banding patterns in both forms 
remained whether alkylation was carried out with iodoacetamide, 
iodoacetic acid or a mixture of both. In addition, there were some 
bands of relatively high pI which were observed only in M-PAP. These 
bands were found in association with some smearing and distortion in the 
surface of the gel. The cause of this distortion is not known and it 
was not observed in A-PAP. Incorporation of nonidet NP40 in the system 
reduced the smearing of these bands but, it did not affect either the 
presence of these extra bands or the distortions in the surface of the 
gel. 0' Farrell (1975) has reported that the presence of multiple bands 
in association with smearing in IEF gels can be due to relative insolu-
bility of certain proteins and that these effects can be improved by the 
presence of nonidet NP40. The hydrophobic properties of M-PAP described 
in this chapter and the previous observations in chapter 2 (Abu-Hasan ~ 
~, 1984) may account for the smearing and the additional bands which 
are observed when the polypeptide is resolved in IEF gels. 
68 
The molecular weight of A-PAP was estimated by gel filtration to be 
121,000 (Abu-Hasan ~ al 1984); this is consistent with the value of 
130,000 MW from non-reducing SDS polyacrylamide gels (Figure 4). The 
evidence from the SDS gels (Figure 4) shows that M-PAP is a homomer of 
69,000 MW subunits and that it contains no other unrelated species of 
polypeptide. In the absence of reduction, M-PAP showed additional 
protein bands of mobilities corresponding to 116,000 and 180,000 MW. 
Whether the 180,000 band represents a trimer or a tetra mer is unclear, 
since direct estimates of molecular weight cannot be obtained for 
disulphide bonded structures (cf Figure 4). However, this value is far 
lower than that of 125,000 mol. wt. which was observed for native M-PAP 
by gel filtration (chapter 2). The discrepancy between the gel 
filtration and electrophoresis data could be explained by the M-PAP 
being composed of either an aggregate of 5 to 6 dimers 00-12 
polypeptides), or a lesser number of dimers together with some non-
proteinaceous material which can be separated by SDS from the 
polypeptide component. Both these types of possibility have been 
raised by Doellgast ~ ~ (1911) in an attempt to examine the structure 
of B-PAP, which in their hands had a molecular weight of over 200,000. 
The effect of Triton X-100 on the electrophoretic properties of M-
PAP in starch gels and in non-denaturing polyacrylamide gels is 
consistent with a hydrophobic property which is expected of an integral 
membrane protein. The observation (Figure 6) of the hydrophobic 
affinity of M-PAP for alkyl agarose strongly supports the hydrophobic 
nature of the M-PAP and provides a useful purification technique for 
this form of the enzyme. The hydrophobicity of M-PAP is probably 
reflected in the chromatographic studies with DEAE Sepharose CL-6B, in 
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which Triton X-l00 appears to change the elution point of M-PAP. The 
enzyme elutes at O.04M and 0.18M NaCI in the presence and absence of 
Triton X-l00 respectively, whereas the elution point of A-PAP did not 
change from 0.1 M NaCI under these condi tions. A similar effect of 
Triton X-l00 on the binding of PAP to DEAE Sephadex was reported by 
Doellgast ~ a}, (1974). Since their studies did not involve a 
detailed analYSis of the different forms of the enzyme, their obser-
vation could be partially due to the hydrophobic character of the M-PAP. 
These observations suggest that the binding of M-PAP to DEAE Sephaarose 
CL-6B involves hydrophobic interactions which are reduced in the 
presence of Triton X-l00. This is in close agreement with the finding 
that lipophilic proteins have a high tendency to bind detergents such as 
Triton X-l00 and deoxycholate (Helenus ~~, 1972). It has been 
proposed that non-ionic detergents bind primarily by hydrophobic 
interactions to hydrophobic regions on the proteins which are occupied 
by lipid in the native membrane (Utermann and Simons, 1974). 
The evidence presented in chapter 2 (Abu-Hasan ~ sJ, 1984) and 
this chapter (Abu-Hasan and Sutcliffe, 1984) indicates that placental 
microvillus plasma membranes contain a hydrophobiC form of PAP which is 
distinct from A-PAP. In certain other systems the fate of a polypeptide 
either to be retained in the cytoplasm, integrated into the membrane, or 
to be secreted from the cell, is determined by the location of 
hydrophobic signal sequences at the ends of the polypeptides. The 
presence of amino-terminal signal sequences on polypeptides determine 
whether they are to be secreted or to be retained in the cytoplasm (see 
Meyer, 1982). The presence of similar sequences at the carboxy-terminal 
ends of immunoglobulin heavy polypeptides determine whether they are to 
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be secreted from the cell, or integrated into the cell membrane as 
surface antibody (Early .ru. .9]., 1980; Singer.ru..9.l 1980). These models 
can cautiously be applied to PAP. Since A-PAP is heavily glycosylated, 
it is probable that it enters the cellular membrane system and that it 
therefore, has an amino-terminal signal sequence. This must also apply 
to M-PAP, since it is found in the microvillus plasma membrane. Either 
of these amino-terminal sequences could be proteolytically cleaved from 
the polypeptides after synthesis. The models also suggest that the M 
polypeptide may differ from A by the presence of another hydrophobic 
sequence at another site. If, as in the case of antibodies, the 
presence or absence of this sequence is controlled not by proteolysis, 
but by a genetic splicing system, then it is not possible to predict 
whether such a sequence would cause a difference in the molecular 
weights of the reduced A and M polypeptides. The difference between the 
mobili ties of the dimers of A and M in SDS gels is probably due to a 
conformational difference. This may be due to differences in their 
primary structures. Another possibility is that A-PAP and M-PAP derive 
from exactly the same polypeptide sequence, but that there is more than 
one conformationally stable state in which the enzymic polypeptide can 
exist, possibly due to heterogeneity in post-translational processing. 
These differing conformational states could substantially effect the 
hydrophobicity and aggregation state of the PAP polypeptide, leading to 
the formation of the distinct and apparently highly stable A and M forms 
of the enzyme. Further discussion of these matters can be seen in 
chapter four. 
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CHAPTER 4 
INTEGRATION OF PLACENfAL ALKAUNE PHOSPHATASE INTO 
THE MICROVIlLUS MEMBRANES 
4.1 I NT ROD U C T ION 
The results reported in the previous chapters have shown that M-PAP 
exhibits the same genetic polymorphism as the A and B forms. It contains 
69K polypeptides and cross-reacts serologically with A-PAP. However, 
compared with A-PAP and B-PAP, M-PAP is more hydrophobic, both in its 
affinity for alkyl agaroses and in needing Triton X-l00 for it to be 
resolved on starch gels (Abu-Hasan and sutcliffe, 1984). Such 
hydrophobic properties may be expected of an integral membrane protein. 
Since M-PAP is associated with the microvillous membrane, it is 
necessary to ask whether the observed differences between M-PAP and A 
and B-PAP could be due to the presence in M-PAP of an intra-membranous, 
hydrophobic amino acid domain which might be specific to M-PAP. The 
results in this chapter establish the orientation of M-PAP in the 
microvillous membrane, and report some structural comparisons between 
the A and M forms of the enzyme. 
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4:2 MATERIALS AND MEllJODS 
4: 2. 1 Materials 
Subtilisin (EC 3.4.21.3) type VIII, trypsin (EC 3.4.21.4), phenyl 
methyl sulfonyl-fluoride (PMSF), p-toluenesulfonyl-L-arginine methyl 
ester (TAME) and all chemicals for the staining and assay of alkaline 
phosphatase were purchased from the Sigma Co. DEAE Sepharose CL-6B and 
Sephadex G150 were obtained from Pharmacia. Ultrogel AcA 34 was 
obtained from LKB. A-PAP, M-PAP and placental microvilli were purified 
as described in the previous chapters. 
4:2.2 Methods 
1. Proteinase Treatment of Microvillous Membranes and Proteins 
The optimal conditions for the release of PAP by subtilisin from 
intact membrane vesicles were established in preliminary experiments 
using different enzyme concentrations and conditions. The following 
standard procedure was then adopted. Microvilli at a protein 
concentration of approximatly 10mg/ml in PBS buffer, pH 7.4 were treated 
with a concentration of subtilisin equal to 1/20 of the concentration of 
microvillous proteins. The reaction was carried out in a final volume 
of 3ml for 3hr at 37°C with frequent shaking. Proteolysis was stopped 
by the addition of PMSF and TAME to final concentrations of 2mM and 
1mg/ml, respectively. The residual membranes were then sedimented at 
100,OOOg for 30 min. Both the supernatant and the residual membranes 
were stored at -200 C. Trypsin cleavage was carried out under the same 
conditions, with the pH adjusted to 7.8. Purified M and A-PAP were 
cleaved in the same way as for microvilli. 
73 
2. Identification of the Amin~terminal Amino Acids 
Edman degradation was carried out on a Beckman 8g0C automatic 
sequencer fitted with cold trap, using 0.25M Quadrol buffer and the 
delivery programme modified by Beckman from (Brauer, Margolies and 
Hober, 1975). Further details have been described by Brett and Findlay 
(1983). Proteins were solubilised and added to the cup in 90~ formic 
acid and mixed thoroughly with 3 mg of polyprene (Tarr, Beecher, Bell 
and McKean, 1978). The resul ting thiazolinones were converted to the 
corresponding phenylthiohydantions (PTH) with 200pl of 20% 
trifluoroacetic acid at 700 C for 15 min. PTH-derivatives were 
identified by reverse phase HPLC using DuPont 8800 pump system and 
quantitated using a Spectra Physics SP4100 computing integrator. The 
gradient was of acetonitrile (20-40%) in 12 mM-sodium acetate as 
modified from Zimmerman, Appella and Pisano (1977). 
3. Polyacrylamide-gel Electrophoresis 
SDS/Tris/polyacrylamide-gel electrophoresis was carried out as 
previously descibed by Laemmli (1970). Samples for electrophoresis 
were made up as described by Sutcliffe ~ .9..l (1980), with the 
modification that the unreduced samples were made up in 0.8% SDS/23% v/v 
glycerol. 
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4:3 RES U L T S 
4:3.1 Released Enzyme Activity 
Preparations of PAP were phenotyped before the enzyme was purified 
or analysed. Proteinase treatment of microvilli, with subtilisin or 
trypsin did not affect the activity of PAP (Table 1). The PAP released 
from microvilli treated with trypsin did not exceed that released in the 
absence of enzyme treatment. Thus trypsin did not release PAP activity 
from microvilli. In contrast, subtilisin solubilization released upto 
80~ of the enzyme activity into the supernatant, leaving about 20~ of 
the total activity associated with the membranes. 
4:3.2 Electrophoresis and Chromatography of 
Subtilisin Released PAP 
The treatment of microvilli or purified M-PAP with subtilisin 
yielded PAP which, on starch gels, showed a single zone of enzyme 
activity of slightly faster mobility than that of native A-PAP 
(Figure1). This form of M-PAP did not require the presence of Triton X-
100 to enter the gel system. On Ultrogel AcA 34 and Sephadex G-150 gel 
filtration chromatography, the subtilisin-cleaved M-PAP co-eluted with 
A-PAP at 130K (Figure 2). Ion-exchange chromatography in DEAE sepharose 
CL-6B revealed a significantly modified elution behaviour of cleaved M-
PAP compared to that solubilized by butanol, with the cleaved product 
eluting between 0.08-0.115M NaCI in the absence of Triton X-l00. This 
elution point is similar to that of A-PAP (0.10 M) and is substantially 
different from that of intact M-PAP (0.18 M under these conditions). 
On SDS gels (Figure 3 tracks 1 and 3 ) aliquots of the subtilisin 
supernatants were found to contain a major polypeptide with a molecular 
weight of 67K which was slightly smaller than the molecular weight of 
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Table 1 The yield of PAP from microvilli treated with protease. 
, , 1 , , , , , , I , , , , , • , 1 , , , , , 1 , , , I , 1 ' 1 1 ' , , , , , , , ) , ) , , ' 1 , , , 1 , , , , , , , , , , ! , I 1 t ·f 1 , , , , t , J 
Microvillus Protease Ratio Enzyme activity expressed as % of initial 
protein (mg) (mg) activity in untreated microvilli 
(a) (b) (a:b) supernatant microvillus pellet 
§ybtUl§ln 
23.75 1.19 20: 1 83.0 22 
23.75 0.59 lto: 1 71.0 25 
23.75 0.12 200:1 66.0 38 
23.75 0.00 9.7 96 
tr;:imaln 
23.75 1.19 20: 1 9.7 96 
! I 1 , , , , , ' , , , , , , , , , 1 , 1 , , , , , , , , , 1 , ' , , , , , , ) , , , , ! , , , 1 ' , , , , , , , • , , , ! 1 , 1 ' , , , ) , t 1 ' , , t 
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nati ve PAP (69K). The bands at 27.6K in tracks 1 and 3 represent 
subtilisin, and the same band is visible in tracks 7 and 8, which have 
been run in a separate gel. Evidence for the 67K peptide being a 
cleaved form of PAP was obtained when it was found that purified 
preparations of M and A-PAP also yield a 67K polypeptide when treated 
with subtilisin (tracks 7 and 8). When membranes previously treated 
with subtilisin (Figure 3, tracks 2 and 4) were compared with that of 
the controls (track 6 ) there was a decrease in the intensity of the 69K 
band and an additional band at 67K, yielding a characteristic pair of 
bands in the gel. It is evident that subtilisin cleavage of purified M 
and A-PAP produced identical SDS profiles, in which a recoverable 
portion of MW 67K was indistinguishable from that cleaved from intact 
microvilli. This suggests that M-PAP is equally suscepti.ble to limited 
proteolysis before or after its removal from the membrane. It also 
shows the presence of a similar cleavage site in the A-PAP polypeptide. 
4:3.3 Amino-terminal sequence 
The differences in the subunit molecular weights between the intact 
(69K) and the subtilisin-cleaved enzyme (67K) was attributed to the 
removal of a small peptide of about 2K believed to be situated in the 
plasma membrane. In order to locate which end of the PAP was inserted 
into the membrane, amino terminal sequences were determined for M-PAP 
before and after subtilisin cleavage. Table 2 shows the sequences of 
the N-terminal 13 amino acids for M-PAP extracted from microvilli with 
butanol. That sequence is compared with M-PAP cleaved from microvilli 
with subtilisin, and also with the sequence for A-PAP. All three 
sequences show identity upto position 13. 
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Table 2 N-terminal amino acid sequence of the butanol extracted H-PAP, 
subtilisin-cleaved H-PAP and A-PAP.-
+ 1 7 13 
Butanol extracted M-PAP : Ile-Ile-Pro-Val-Glu-Glu-Glu-Asn-Pro-Asp-Phe-Trp-Asn-
++ 
Subtilisin cleaved M-PAP: Ile-Ile-Pro-Val-Glu-Glu-Glu-Asn-Pro-Asp-Phe-Trp-Asn-
+ 
Butanol extracted A-PAP: Ile-Ile-Pro-Val-Glu-Glu-Glu-Asn-Pro-Asp-Phe-Trp-Asn-
* The phenotypes used for this study were SS for M-PAP and pooled 
phenotypes for A-PAP. 
+ Purified as described (Abu-Hasan and Sutcliffe, 1984). 
++ Purified from the supernatant of subtilisin treated microvilli by 
ion-exchange chromatography and gel filtration (see text). 
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4:3.4 The Behaviour of Subtilisin-cleaved PAP on 
Non-redusing SDS Gels 
In the previous chapters SDS gels showed mobility differences 
between the dimers of M and A PAP, corresponding to approximatly 116K 
and 130K, respectively. These differences were believed to be due to 
conformational differences. Thus, after cleavage with subtilisin, M and 
A-PAP were analysed on SDS gels in the absence of reduction. The 
results (Figure 4 track 3) show cleaved M-PAP with an apparent molecular 
size of 130K , with a mobility clearly slower than that of uncleaved M-
PAP (118K ; track 4). This was not the case for A-PAP which, when 
cleaved, resulted in a slight decrease in its apparent molecular size 
by about 2K (track 2). Variations in the mobilities of the different 
allelic forms of PAP were also observed when subtilisin-cleaved M-PAP 
from placental micovilli of SS, FF, and FS phenotypes (Figure 4 tracks 
6,7 and 8, respectively) were analysed under these conditions. 
Molecular size estimates for the SS and FF phenotypes in the absence of 
reduction were 129K and 124K, respectively. 
4:3.5 The Effect of Trypsin Solubilization on PAP 
Trypsin treatment failed to release microvillous PAP activity above 
control levels (Table 1), and no 69K band was detected in the membrane 
supernatants (Figure 5 tracks 2 and 3). However, the intensity of the 
M-PAP band in the membrane pellet was decreased by the addition of 
trypsin (tracks 5-7), with the concomitant appearance of a band of 
about 60K (tracks 5-7) which was absent from the control (track 4). 
Butanol extracts of both the control and the trypsin-treated membrane 
pellets (tracks 8 and 9 respectively) showed several bands including 
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prominent ones at 69K and 60K which were found only in trypsin-treated 
membranes. Similar results were obtained when purified M and A-PAP were 
digested with trypsin (Figure 5 track 11). Although trypsin was unable 
to release M-PAP from the membrane, it appears to cleave a portion of 
about 9K from one end of the subunit, leaving an enzymatically active 
portion of PAP associated with the membranes. 
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Figure 1. Starch gel electrophoresis of subtilisin-cleaved M-PAP. 
Aliquots of placental microvillous membranes of SS, FS, and FF 
phenotypes were incubated with subtilisin for 3 h at 37°C at a ratio of 
10:1 (w/w PAP:protease). After incubation, the supernatants were 
separated and analysed on starch gels containing 0.5% Triton X-1 00; 
together with butanol extracts of untreated microvilli of corresponding 
phenotype. 
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Figure 2. Gel filtration of placental alkaline phosphatase after 
proteolytic cleavage from microvilli. 
After subtilisin cleavage of microvilli, the released PAP was applied 
to an AcA34 column (25x1cm2) and eluted in Tris-succinate buffer pH 7.4. 
The enzyme activity was plotted against the elution volume (-----) and 
compared with the elution of a butanol extract of PAP ( ) prepared 
without the addition of subtilisin. The elution ranges of alpha-2-
macroglobulin (O!' 2M), IgG and human serum albumin (Alb.) were 
determined. 
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Figure 3. SDS-polyacrylamide gels of subtilisin treated placental 
microvillous membranes and purified PAP. 
A suspension of microvillous membranes was incubated for 3 h at 370 C 
with subtilisin at a ratio (w/w PAP:protease) of 10:1 or 20:1 or without 
subtilisin. After incubation, the samples were centrifuged at 100,000g 
for 30 min. The supernatants were removed and the pellets were washed 
once and resuspended in PBS. Aliquots of the supernatants (tracks 1,3 
and 5) and the pelleted membranes (tracks 2,4 and 6) were analysed on 
SDS-PAGE. Microvilli were treated with a ratio 10:1 subtilisin in 
tracks 1 and 2, with 20:1 subtilisin in tracks 3 and 4, and without 
subtilisin in tracks 5 and 6. Tracks 7-10 contain purified samples of 
A-PAP and M-PAP either treated with subtilisin or not, as indicated in 
the figure (A=A-PAP; M=M-PAP; -=control; +=after treatment with 
subtilisin) • 
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Figure 4. Subtilisin cleavage of H-PAP and A-PAP resolved on SDS 
polyacrylamide gel in the absence of reduction. 
Purified preparations of M and A-PAP were incubated with subtilisin for 
3 h at 370 C at a ratio of 10: 1 (w/w). The cleaved proteins were then 
analysed on SDS gels in the absence of reducing agents. Tracks 1 and 5 
contain A-PAP. Tracks 2 and 3 contain subtilisin treated A and M-PAP, 
respectively. Track no. 4 contains M-PAP. Tracks 6,7,8 and 9 show the 
mobility of subtilisin cleaved M-PAP obtained from separate samples of 
microvilli with PAP phenotypes of FS, SS, FS and FF respectively. The 
three bands in the FS phenotype are marked by black dots. 
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Figure 5. 50S polyacrylamide gel of microvilli and purified PAP 
after treatment with trypsin. 
A1iquots of microvillous membrane suspension were incubated for 3h at 37 
oC with trypsin at ratios (w/w PAP:protease) of 10:1, 20:1 and 40:1. 
The results are shown in tracks 1-9. After incubation and 
centrifugation, the membrane supernatants were resolved in SDS gels : 
track numbers: 1 (no trypsin), 2 (20: 1 trypsin), 3 (10: 1 trypsin). The 
pellets were analysed in SDS gel track numbers: 4 (no trypsin), 5 
(40:1 trypsin), 6 (20:1 trypsin) and 7 (10:1 trypsin). 
A1iquots of untreated membranes and those treated with 10:1 trypsin were 
also extracted with 50% butanol; the aqueous phases of these extractions 
were resolved in tracks 8 and 9, respectively. Track no. 10 contains M-
PAP and no 11 contains M-PAP treated with trypsin. 
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Figure 6. SDS polyacrylamide gel of ion-exchange fractions from a 
microvillus preparation containing degraded H-PAP. 
A butanol extract of placental microvillus membranes were applied to 
DEAE sepharose CL-6B. The elution was carried out with a gradient of 
increasing sodium chloride concentration. The fractions were assayed on 
starch gels and then aliquots of the fractions containing M and A-PAP 
were analysed on SDS-PAGE. Tracks 1,2 and 3 show M-PAP with a doublet 
band at 67K and 69K. Tracks 6,7 and 8 contain A-PAP. The band at 86K 
in tracks 4 and 5 is transferrin. 
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4:4 DIS C U S S ION 
4:4.1 Location of the Membrane Domain of M-PAP 
Detergents and proteinases are commonly used as methods for 
solubilizing integral membrane proteins; they release microvillar 
membrane hydrolases of kidney and intestine without loss of hydrolase 
activity. Detergent solubilization yields a protein of intact (native) 
primary structure, whereas proteases cleave off the external 
(hydrophilic) domains of proteins from the hydrophobic peptides 
integral to the plasma membrane (for review, see Kenny and Maroux, 
1982). The available evidence indicates that M-PAP behaves somewhat 
similarily to kidney and intestinal hydrolases. The majority of M-PAP 
can only be released from microvilli by delipidation or proteolysis. 
Treatment of placental microvillous membranes with subtilisin releases 
PAP with a polypeptide molecular weight of about 2K smaller (67K) than 
the molecular weight of native M-PAP obtained by butanol extraction of 
microvilli (69K). It is probable that this 2K difference in molecular 
weight is due to the presence of a membrane binding domain in the 
butanol form (M-PAP) which is absent in the subtilisin released form. 
A small hydrophobic domain which may function in this way has been 
identified in intestinal alkaline phosphatase (Komoda ~.9..l, 1981). 
Integral proteins can interact with the phospholipid bilayer in various 
ways, particularly with respect to the number and the location of the 
amino acids which are embedded in the membrane. M-PAP seems to fit in 
the same category as cytochrome b5, NADH cytochrome b5 reductase and 
most of the kidney and intestinal microvillar hydrolases in which most 
of the protein mass is located on one side of the membrane and only a 
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small peptide segment lies within the membrane. This differs from other 
integral membrane proteins, such as rhodopsin and erythrocyte band III, 
which have most of their mass inserted in the lipid bilayer (for 
reviews, see Kenny and Maroux, 1982; Lodish, Braell, Schwartz, Strous 
and Zilberstein, 1981). 
N-terminal amino acid sequencing was carried out in order to 
determine whether M-PAP is integrated into the plasma membrane at its 
carboxy-terminus or elsewhere. Previous dansyl-Edman sequencing studies 
on PAP, purified from butanol extracts of total placental homogenate, 
yielded the amino-terminal sequence of Ile~IlejP,cq~Val. (Green and 
Sussman, 1973). The sequencing data (Table 2) agree and extend those 
findings. It also shows that native and subtilisin cleaved M-PAP show 
common N-termini, indicating that the 2K membrane binding domain must be 
located at the C-terminus of the PAP polypeptide. Limited sequence 
studies on detergent and proteolysed forms of human and pig intestinal 
alkaline phosphatases (Komoda.ru:;. ru., 1981; Colbeau and Maroux, 1978) 
have shown that intact and proteolysed forms had the same N-terminal 
peptides (in the human Phe,Ile~P,tQ and in the pig Phe.Ile) , suggesting 
that both enzymes are integrated at their carboxy-termini. Alkaline 
phosphatases therefore contrast with some of the other microvillar 
hydrolases of kidney and intestine which are integrated at the N-
terminal (Kenny and Maroux, 1982). The incidence of hydrophobic amino 
acids in the first four pOSitions in PAP (Table 2) is not surprising. 
Many other secreted proteins have 2-~ such residues which are probably 
the carboxyl end of the hydrophobic leader sequence the majority of 
which has been cleaved off during polypeptide maturation (Harwood, 
1980). 
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Since M-PAP consists of two identical 69K subunits it is probable 
that it is integrated into the membrane by both anchoring domains. 
However, it is worth noting that a few samples of M-PAP prepared by 
butanol extraction showed a doublet band at 67K and 69K (Figure 6 tracks 
1-3), most probably due to endogenous proteases acting at the junction 
between the hydrophilic and the binding domain toward the carboxyl end 
of the molecule. These samples were probably exceptional, care over 
the duration and temperature of the microvillous extraction usually 
prevents the formation of the 67K band. It is not clear why such 
degradation was not found in the A-PAP fractions prepared from those 
samples (Figure 6 tracks 6-8). Perhaps the residual A-PAP associated 
with the microvillous preparations is entrapped within the membrane 
vesicles, and hence protected from proteolysis. 
Since M-PAP has an affinity for hydrophobic alkyl agarose which 
allows it to be separated from A-PAP, we may consider the working 
hypothesis that M is an integral membrane protein because it differs 
from.A-PAP in having a hydrophobic carboxy-terminal domain anchoring it 
in the membrane. However, A-PAP and M-PAP have similar CNBr maps and 
both express the same genetic polymorphism, located in the 67K 
hydrophilic fragment of the polypeptide. If this polymorphism defines 
a unique, allelic exon then the presence of different carboxy-termini 
could imply a process of exon shuffling, or altered transcription or 
altered maturation of the primary transcript. Such a phenomenon was 
found in the lymphocyte IgM molecule, which exists as a secretory water-
soluble molecule as well as an integral membrane protein. The two forms 
of the molecule are so similar that for a long time no difference 
between them could be detected. More recently, it has been shown that 
the difference between the two forms reside at the C-terminus of the p 
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chains; membrane-bound p chains have a 26 residue long stretch of 
hydrophobic amino acids, absent from secretory p chains (Singer and 
Singer, 1980; Rogers, Early, Carter, Bond, Hood and Wall, 1980; Early, 
Rogers, Davis, Calame, Bond, Wall and Hood, 1980). It has been shown 
that the two forms of the molecule are coded for by separate messenger 
RNAs, which originate by different splicing of a common precursor RNA 
(Rogers ~ sl, 1980; Early ~ sl, 1980). However, we must also consider 
that the differences could be due to post-translational events, though 
it is difficult to be clear about mechanism. Glycosylation could 
render a hydrophobic ("M") domain relatively hydrophilic (making it 
perhaps into "A"), but if glycosylation occurs ,Hithin the microsomal 
membrane system of the cell, it is difficult to understand how 
glycosylation could occur to a domain which, being up to that point 
hydrophobic, would presumably be located within the plasma membrane. 
Other modifications (e.g. phosphorylation) meet with similar 
difficulties, unless it is possible to modify the nascent polypeptide 
chain before it enters the endoplasmic reticulum. Since the reduced 
69K polypeptides of M and A are indistinguishable on SDS gels (69K), as 
also are the 67K subtilisin polypeptides, it seems improbable that A is 
a proteolytic product of M. 
~:q.2 Conformational Heterogeneities 
Under non-reducing conditions subtilisin cleaved and uncleaved M-
PAP had molecular sizes of 130K and 118K respectively; the cleaved form 
showing a bigger apparent molecular size (Figure 4). This unexpected 
finding might have been due to the hydrophobic segment in uncleaved M-
PAP binding more SDS and hence moving faster in the gel due to the extra 
negative charge. However, this is unlikly as such an effect did not 
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occur under reducing conditions. The difference in the effect of 
subtilisin on the two forms of the enzyme argues that the dimers of A 
and M probably have different conformations. These conformations might 
be caused by structural differences inherent in the 67K domains. 
Alternatively, they could be due to a more complex interaction in the 
intact molecules, whereby the 2K fragments of A and M induce different 
conformational folding (and perhaps disulphide bonding) in the 67K 
domains. Further sequence data is awaited to help answer these 
questions. 
Molecular size variations of the different allelic forms were 
observed in starch gels, and in SDS gels in the absence of reduction, 
both for the cleaved and uncleaved forms of PAP (Figure 4). Since this 
effect is not lost by the removal of the 2K domain, this molecular 
heterogeneity must reside within the 67K domain of the molecule. On SDS 
gels, the fast and slow phenotypes of intact A-PAP were reported to have 
apparent dimeric molecular weights of 119K and 122K, respectively 
(Holmgren and Stigbrand, 1976). Although our estimates are higher than 
these molecular sizes, we confirm the existence of this heterogeneity. 
It is unusual to be able to distinguish polymorphic forms of enzymes in 
SDS gels, even in the absence of reduction. Since the allelic forms of 
PAP are indistinguishable in SDS gels Hl1b reduction, the differences in 
the sb§ence of reduction suggest that the allelic forms of PAP differ 
substantially in conformational structure. We cannot deduce the number 
of amino acid changes needed to produce such conformational differences. 
Simple amino acid substitutions are generally thought to account for 
enzyme polymorphisms, and this is the case in some common variants of 
haemoglobin as well as in the recently reported analysis of Drosophila 
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alcohol dehydrogenase (Kreitman, 1983). Such substitutions might cause 
conformational changes big enough either to be detectable in non-
reducing SDS gels, or to result in notable allele-specificity amongst 
monoclonal antibodies to PAP (Slaughter ~ sj, 1981, 1983; Millan ~ sl, 
1982). However, multiple amino acid substitutions can sometimes underly 
allelic differences, as has been found from sequencing analyses of 
Kvist 
histocompatibility antigens (Weiss, Golden, Kakut, Millor, Fahren'and 
Flavell, 1983). The matter must remain open so far as PAP is concerned 
until more sequence data is available. 
4:4.3 Native Molecular Weight Estimates 
Molecular weight estimates from gel filtration of M-PAP (725,000) 
suggest that the enzyme is in an aggregated form (chapter 2). After 
subtilisin treatment M-PAP was much reduced in size and co-eluted with 
A-PAP (130K). This indicates that M-PAP aggregates through non-covalent 
associations between hydrophobic C-termini. It remains to be determined 
whether this aggregation exists in intact microvillous membranes. High 
molecular weight forms of PAP and PAP-like enzymes have been previously 
reported. B-PAP has a molecular weight of about 200,000 (Doellgast ~ 
~l, 1977). A large hydrophobic form of heat stable alkaline 
phosphatase has been described in JAR choriocarcinoma cells by Neuwald 
and Brooks (1981). In that case, the enzyme had a molecular weight of 
at least 225,000, though large forms of the enzyme were also evident in 
non-denaturing gels. The enzyme could be converted from a slow mobility 
hydrophobic form to a faster mobility, hydrophilic form through trypsin 
proteolysis. Though there are parallels between JAR alkaline phosphatase 
and placental microvillous AP, the JAR enzyme is more sensitive to 
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inhibition by phenylalanylglycylglycine than is PAP, and M-PAP cannot be 
cleaved into hydrophobic and hydrophilic domains by trypsin treatment, 
since that protease primarily cleaves the PAP polypeptide at a position 
close to its NH2-terminus. This difference may be indicative of 
fundamental structural differences between PAP and the PAP-like enzyme 
of JAR cells. 
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CHAPTER 5 
GENERAL DISCUSSION 
General Discussion 
This chapter focuses attention on the possible relationship between 
the microvillous alkaline phosphatase (M-PAP) and A-PAP and examines 
some areas of interest for fUture experimental research into the nature, 
genetics and function of placental alkaline phosphatase. 
The results presented in the previous chapters demonstrate the 
existence of a membrane bound form of human placental alkaline 
phosphatase (M-PAP) in association with the microvillous plasma 
membranes. The physical characteristics displayed by M-PAP on gel 
f11 tration (chapter 2 fig 6-8), ion-exchange chromatography (chapter 3 
fig 1) and on hydrophobic chromatography (chapter 3 fig 1) were typical 
of integral membrane proteins, and distinct from those of the previously 
described A and B forms of PAP prepared from total placental extracts. 
Such behavioural differences appear to support the view that M-PAP could 
represent a product of a distinct gene from that of A-PAP. However, 
the expression of the same genetic polymorphism (chapter 2 fig 4) and 
the identical N-terminal 13 amino acid sequences (chapter 4 table 2) in 
both forms suggests that A and M-PAP are very closely related and 
probably, at least in part, share the same enzymatic polypeptide. 
Evidence of antigenic cross-reactivity (chapter 2 fig 5), and the data 
on heat stability (chapter 2 fig 9), CNBr peptide maps (chapter 3 fig 
6), cleavage sites for subtilisin (chapter 4 fig 3) and trypsin (chapter 
4 fig 5), subunit molecular weight (chapter 3 fig 3) and kinetic studies 
(chapter 3 table 1) also strongly argue against the involvement of two 
distinct genes for the expression of the A and M forms of the enzyme. 
If so, then one would be led to believe that both forms are produced 
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essentia]y by a single gene and therefore the different properties of A 
and M-PAP could be due to post-translational processing or differential 
splicing. Post-translational processing such as glycosylation, 
phosphorylation, acylation and proteolysis may give rise to different 
functional and structural properties displayed by these molecules. The 
finding of a similar subtilisin cleavage in A-PAP, as judged on SDS 
polyacrylamide gels (chapter 4 fig 3), argues against this form being a 
subtilisin cleavage product of M-PAP in vitro. However, this 
possibility is only weakly supported by SDS-electrophoretic patterns, 
since small differences in molecular weight (69K versus 67K) cannot be 
definitely shown. Whether a similar in vivo proteolytic cleavage 
accounts for A-PAP is not clear. It may be that covalently bound lipid 
is associated with the carboxy-terminal of M-PAP and accounts for its 
behavioural characteristics. Such bound lipid has been found in 
association with the membrane-spanning fragments of certain viral 
glycoproteins (Schmidt, Bracha, and Schlesinger, 1979; Schmidt and 
Schlesinger, 1979; Schmidt, 1982) and with the variant surface 
glycoproteins of Trypanosoma brucei (Cardoso de Almeida and Turner, 
1983). In the latter case both lipids and carbohydrates were found to 
bind to the carboxy-terminal domain. These fatty acid residues were 
assumed to provide a type of anchor that could bind these glycoproteins 
to the membranes. Furthermore the process of acylation and deacylation 
reported by Bishr Omary and Trowbridge (1981) for the transferrin 
receptors in human lymphoma cells, would modulate the affinity of a 
glycoprotein for the membrane. The exact mechanism of the attachment of 
these glycoproteins is poorly understood (Schmidt, 1982). 
Subtilisin digestion has been used as an alternative to butanol 
solubilization for the release of M-PAP. The mechanism of release 
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appears to involve proteolytic removal of the major portion of the 
molecule (67K) from a short anchoring peptide, approximately 15-20 amino 
acids at the carboxy-terminal (chapter 4 fig 3). The removal of the 
binding domain of M-PAP has not been shown to affect the catalytic 
acti vi ty of the enzyme (chapter 4 table 1). Nevertheless this domain 
exerts a major influence on the structural properties of M-PAP. 
Following digestion with subtilisin, M-PAP showed behavioural 
characteristics similar to that of A-PAP under different electrophoretic 
and chromatographic systems. On starch gels cleaved M-PAP did not 
require the presence of Triton X-100 and showed a slightly faster 
mobi11 ty than that of A-PAP (chapter 4 fig 1). On SDS polyacrylamide 
gels both forms showed very similar mobilities (chapter 4 fig 3). 
Cleaved M-PAP was also found to elute with A-PAP in both ion-exchange 
and gel filtration columns (chapter 4 fig 2). This change in the 
behavioural properties in M-PAP appears to correlate with the removal of 
approximately 15-20 amino acid residues from the carboxy-terminal. 
These findings together with the behaviour of the subtilisin cleaved and 
un-cleaved dimer1c polypeptides of both forms on SDS polyacrylamide 
gels in the absence of reduction (chapter 4 fig 4), where the removal of 
the binding domain of M-PAP seems to have a significant influence on the 
compaction of the molecule, provide some indirect evidence for the 
presence of some structural differences between the carboxy termini of 
these two molecules. Since M-PAP displays physical characteristics 
typical of integral membrane proteins, a more likely hypothesis is that 
M differs from A-PAP in having a hydrophobic carboxy-terminal domain 
anchoring it in the membrane. However, both A and M-PAP express the 
same genetic polymorphism (chapter 2 fig 4), located in the 67K 
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hydrophilic fragment of the polypeptide and have identical N-terminal 
amino acid sequences up to position 13 (chapter 4 table 2). If this 
polymorphism defines a unique shared exon between A and M-PAP, then the 
presence of different carboxy-termini would imply that their C-termini 
are encoded on different exons. This will also require the presence of 
different RNA splicing sites. Such a phenomenon exists for the 
membranous and secreted forms of immunoglobulins and is brought about by 
separate species of mRNA differing only in their 3' coding regions 
(Rogers, ~.al, 1980; Early, ~.9.l, 1980 ). A possible role for 
alternative acceptor splice sites in the mouse H-2K gene has been 
described by Kress, Glaros, Khoury and Jay, (1983) in which two 
alternative transcripts were found to encode H-2K antigens differing in 
their C-termini. Different models can be proposed to achieve the two 
forms of PAP differing in their C-termini. RNA polymerase could read 
through the whole gene and generate nuclear RNAs with common 3' ends 
(containing all five exons), or transcription could be terminated at 
different sites producing RNAs with different 3' ends. Subsequent 
differential splicing of the exons 4 and 5 in both models could give 
rise to the A and M forms of mRNA which would encode the two forms of 
the enzyme (see Fig. 1). 
5:1 Further Characterization of the C-termini 
At this stage of knowledge one can only speculate as to the 
relationship between the A and M forms of the enzyme. Whatever the 
physical basis for the difference between the two forms, it seems 
probable that its elucidation, perhaps involving direct amino acid 
sequencing of the carboxy-termini of the A and M forms, will contribute 
to the knowledge of the biosynthesis and expression of membrane 
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Figure 1. Proposed RNA processing patterns that could generate two 
different mRNAs. 
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proteins. Since subtilisin treatment of the butanol form of M-PAP 
effectively cleaves the hydrophilic domain (67K) from the binding domain 
(2K), it is possible to isolate and characterize these latter fragments. 
However, there are inherent difficulties in the purification, handling 
and detection of such peptides. The use of LH 20 columns with different 
solvent systems seems to isolate small hydrophobic peptides (Brett and 
Findlay, 1983). The detection of these peptides can be facilitated by 
labelling with 125r as the probability that such hydrophobic segments 
containing tyrosine residues is high. It is also possible to improve the 
resolution of SDS polyacrylamide gels and to detect small fragments down 
to 10 amino acids by increasing the bis acrylamide and the incorporation 
of Urea in these gels (Swank and Munkres, 1971). 
5:2 The Need For Molecular Biological Studies 
There 1s no doubt that molecular studies of the PAP gene at the DNA 
level would give some insight into the problem of the expression of 
membranous and non-membranous forms of PAP. It would also serve to 
determine the genetic basis of the allelism, the nature and location of 
AP loci in placental and other DNA, as well as to enquire into the 
nature of PAP-like isoenzymes in tumours. cDNA clones from mRNA of PAP, 
can be made by priming reverse transcription either with oligo dT, or 
with synthetic oligonucleotides. The amino acid sequence found in this 
study can provide the bases for 4 alternative 11-nucleotide oligomers 
(with two mixed sites), one of these oligomers would be complementary 
to PAP mRNA. Although PAP is expressed in large quantities at term, D. 
A. Nickson finds that the message is not present at high levels and 
therefore is difficult to isolate. This could be due to the stability 
98 
of the enzyme and therefore low levels of the mRNA, or to the 
inactivation of the gene prior to. parturition (Nickson, personal 
communication). Selected tumour cell lines such as HeLa subline TCRC-1, 
(Singer and Fishman, 1974; Beckman ~~, 1970), or Osteosarcoma cells 
(Singh, Tsang and Blakmore, 1978) which have been found to produce PAP, 
on the basis of electrophoretic and inhibition studies, might be a rich 
source for PAP message. However, the only problem in dealing with such 
cell lines is the lack of structural stUdies on the enzyme produced in 
comparison with PAP. 
An alternative strategy is to probe a cloned genomic library using 
synthetic oligomers. This technique has been used for multiple copy-
genes where there is no requirement for screening large number of clones 
whereas looking for a single-copy gene, which might be the case for PAP, 
would involve analysing a large number of clones some of which might be 
hybridizing due to the presence of similar sequences in other parts of 
the genome, and not PAP gene itself. The 11-oligonucleotide oligomers 
could be extended by using them as a primer for mRNA reverse 
transcription. Such a possibility will greatly reduce the number of 
genomiC clones that would hybridize with the probe. However, the 
advantages of this strategy are that it would circumvent the potential 
problem of cDNA cloning of mRNA which might be unstable or present at 
low concentrations. It would also detect the presence of other 
sequences involved in the control and expression of PAP, should they 
exist. 
5:3 Nature and Origin of Serum PAP 
Placental alkaline phosphatase becomes detectable in the serum of 
pregnant women between the 16th and 20th weeks of pregnancy, increasing 
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progressively up to the onset of labour and disappearing within three to 
six days of the delivery of the placenta (Moss, 1982). Previous studies 
on serum PAP did not involve any structural studies neither in 
comparison with the A and B forms of the enzyme nor with other alkaline 
phosphatases. The methods employed by various investigators were 
restricted to heat inactivation, the use of inhibitors, immunoassays and 
starch gel electrophoresis. The allotypic variation in electrophoretic 
mobility that is characteristic of the isoenzyme prepared from placentae 
is reflected also in serum (Boyer, 1961; Beckman, Bjorling and 
Christodoulou, 1966). This sera seems to contain mainly the A form of 
PAP and some of the B form which can be seen late in pregnancy (Ghosh 
and Fishman, 1914). It is not yet known whether PAP is actively 
secreted into the maternal blood or to what extent microvillous PAP from 
syncytiotrophoblast microvilli that have broken away into maternal 
circulation account for PAP levels during pregnancy. The finding that 
microvillous M-PAP can be proteolytically cleaved from the membranes to 
yield a form with a mobility slightly faster than that of A-PAP on 
starch gels raised the question whether M-PAP contributes to serum PAP 
in a similar way. This should now be taken into consideration when 
starch gel zones of acti vi ty of pregnancy sera are being interpreted. 
It is also of great importance to ask whether M-PAP has any clinical 
value in monitoring the rate of loss of microvilli in normal and 
complicated pregnancies. 
5:4 Candidate Substrates for PAP 
Despite the quantity of PAP in microvillous membranes and in 
pregnancy sera, its precise biological function is not clear. This 
uncertainty applies to other alkaline phosphatases, though a variety of 
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tentative hypotheses have been advanced (see, McComb, 1979). Alkaline 
phosphatases from three different preparations (calf intestine, bovine 
liver, and Escherichia coli), have been found in vitro to 
dephosphorylate phospho-tyrosine-histones as well as some other membrane 
proteins (Swarup, Cohen, and Garbers, 1982). It was also found that 
some human tumour cells contain microsomal alkaline phosphatases which 
can dephosphorylate receptors of epidermal growth factor (EGF) after the 
receptor had been phosphorylated by EGF (Horlein, Gallis, Brautigan, and 
Bornstein, 1982). EGF receptors exist on membranes prepared from whole 
placentae (O'Keefe, Hollinbergand, and Cuatrecasas, 1974) and were also 
reported to exist on placental microvillous plasma membranes (Richards, 
Beardmore, Brown, Molloy and Johnson, 1983). It is interesting to 
speculate that the expression of PAP in syncytiotrophoblast may control 
the binding of EGF and thus reduce the ability of the terminally 
differentiated syncytium to respond to EGF. 
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